<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">108562</article-id>
<article-id pub-id-type="doi">10.7554/eLife.108562</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.108562.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.3</article-version>
</article-version-alternatives>
<article-categories><subj-group subj-group-type="heading">
<subject>Biochemistry and Chemical Biology</subject>
</subj-group>
</article-categories><title-group>
<article-title>D-serine suppresses one-carbon metabolism by competing with mitochondrial L-serine transport</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5352-8595</contrib-id>
<name>
<surname>Suzuki</surname>
<given-names>Masataka</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="author-notes" rid="n1">#</xref>
<email>masataka.s@keio.jp</email>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Adachi</surname>
<given-names>Kenichiro</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="author-notes" rid="n1">#</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wiriyasermukul</surname>
<given-names>Pattama</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fukumura</surname>
<given-names>Mariko</given-names>
</name>
<xref ref-type="aff" rid="a5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tamura</surname>
<given-names>Ryota</given-names>
</name>
<xref ref-type="aff" rid="a5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hirano</surname>
<given-names>Yoshinori</given-names>
</name>
<xref ref-type="aff" rid="a6">6</xref>
<xref ref-type="aff" rid="a7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aizawa</surname>
<given-names>Yumi</given-names>
</name>
<xref ref-type="aff" rid="a8">8</xref>
<xref ref-type="aff" rid="a9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Miyamoto</surname>
<given-names>Tetsuya</given-names>
</name>
<xref ref-type="aff" rid="a10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Taniguchi</surname>
<given-names>Sakiko</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Toda</surname>
<given-names>Masahiro</given-names>
</name>
<xref ref-type="aff" rid="a5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Homma</surname>
<given-names>Hiroshi</given-names>
</name>
<xref ref-type="aff" rid="a10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kanekura</surname>
<given-names>Kohsuke</given-names>
</name>
<xref ref-type="aff" rid="a11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yasuoka</surname>
<given-names>Kenji</given-names>
</name>
<xref ref-type="aff" rid="a6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kanai</surname>
<given-names>Takanori</given-names>
</name>
<xref ref-type="aff" rid="a12">12</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sugimoto</surname>
<given-names>Masahiro</given-names>
</name>
<xref ref-type="aff" rid="a8">8</xref>
<xref ref-type="aff" rid="a9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nagamori</surname>
<given-names>Shushi</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yasui</surname>
<given-names>Masato</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5093-2987</contrib-id>
<name>
<surname>Sasabe</surname>
<given-names>Jumpei</given-names>
</name>
<xref ref-type="aff" rid="a13">13</xref>
<xref ref-type="aff" rid="a14">14</xref>
<email>sasabe@keio.jp</email>
</contrib>
<aff id="a1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02kn6nx58</institution-id><institution>Department of Pharmacology, Keio University School of Medicine</institution></institution-wrap>, <city>Tokyo</city>, <country country="JP">Japan</country></aff>
<aff id="a2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04b6nzv94</institution-id><institution>Division of Infectious Diseases, Brigham and Women’s Hospital</institution></institution-wrap>, <city>Boston</city>, <country country="US">United States</country></aff>
<aff id="a3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/039ygjf22</institution-id><institution>Center for SI Medical Research and Department of Laboratory Medicine, The Jikei University School of Medicine</institution></institution-wrap>, <city>Tokyo</city>, <country country="JP">Japan</country></aff>
<aff id="a4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04cd75h10</institution-id><institution>Department of Biological Chemistry, Faculty of Agriculture, Iwate University</institution></institution-wrap>, <city>Iwate</city>, <country country="JP">Japan</country></aff>
<aff id="a5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02kn6nx58</institution-id><institution>Department of Neurosurgery, Keio University School of Medicine</institution></institution-wrap>, <city>Tokyo</city>, <country country="JP">Japan</country></aff>
<aff id="a6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02kn6nx58</institution-id><institution>Department of Mechanical Engineering, Keio University</institution></institution-wrap>, <city>Yokohama</city>, <country country="JP">Japan</country></aff>
<aff id="a7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/023rffy11</institution-id><institution>Laboratory for Computational Molecular Design, RIKEN Center for Biosystems Dynamics Research (BDR)</institution></institution-wrap>, <city>Osaka</city>, <country country="JP">Japan</country></aff>
<aff id="a8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00k5j5c86</institution-id><institution>Institute of Medical Science, Tokyo Medical University</institution></institution-wrap>, <city>Tokyo</city>, <country country="JP">Japan</country></aff>
<aff id="a9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02kn6nx58</institution-id><institution>Institute for Advanced Biosciences, Keio University</institution></institution-wrap>, <city>Tsuruoka</city>, <country country="JP">Japan</country></aff>
<aff id="a10"><label>10</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f2txz25</institution-id><institution>Graduate School of Pharmaceutical Sciences, Kitasato University</institution></institution-wrap>, <city>Tokyo</city>, <country country="JP">Japan</country></aff>
<aff id="a11"><label>11</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00k5j5c86</institution-id><institution>Department of Pharmacology, Tokyo Medical University</institution></institution-wrap>, <city>Tokyo</city>, <country country="JP">Japan</country></aff>
<aff id="a12"><label>12</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02kn6nx58</institution-id><institution>Department of Internal Medicine, Keio University School of Medicine</institution></institution-wrap>, <city>Tokyo</city>, <country country="JP">Japan</country></aff>
<aff id="a13"><label>13</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02kn6nx58</institution-id><institution>Laboratory of Electron Microscope and Chiral Biology, Keio University School of Medicine</institution></institution-wrap>, <city>Tokyo</city>, <country country="JP">Japan</country></aff>
<aff id="a14"><label>14</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02kn6nx58</institution-id><institution>Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q), Keio University</institution></institution-wrap>, <city>Tokyo</city>, <country country="JP">Japan</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Parker</surname>
<given-names>Benjamin L</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>The University of Melbourne</institution>
</institution-wrap>
<city>Melbourne</city>
<country country="AU">Australia</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Maduke</surname>
<given-names>Merritt</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>Stanford University</institution>
</institution-wrap>
<city>Stanford</city>
<country country="US">United States</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<fn id="n1" fn-type="equal"><label>#</label><p>These authors contributed equally.</p></fn>
<fn fn-type="coi-statement"><p>Competing interests: No competing interests declared</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2025-09-26">
<day>26</day>
<month>09</month>
<year>2025</year>
</pub-date>
<volume>14</volume>
<elocation-id>RP108562</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2025-08-04">
<day>04</day>
<month>08</month>
<year>2025</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2025-08-05">
<day>05</day>
<month>08</month>
<year>2025</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.09.03.610855"/>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2025, Suzuki et al</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Suzuki et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-108562-v1.pdf"/>
<abstract>
<title>Abstract</title>
<p>L-serine serves as a central metabolic node that integrates glycolytic flux, lipid metabolism, and one-carbon metabolism. In the mature central nervous system, L-serine is actively stereo-converted to D-serine, which functions as a neurotransmitter. However, the role of D-serine in cellular metabolism remains unclear. Here, we show that D-serine competes with mitochondrial L-serine transport, thereby suppressing one-carbon metabolism. Metabolomic analysis revealed that D-serine reduces intracellular glycine and formate levels, indicating inhibition of the initial step of the one-carbon pathway. Molecular dynamics simulations and enzymatic assays revealed that D-serine has low affinity for serine hydroxymethyltransferase 2 (Shmt2), which catalyzes the first step in mitochondrial one-carbon metabolism, and does not directly inhibit its activity. Instead, membrane transport assays demonstrated that D-serine competes with mitochondrial L-serine transport, depleting the substrate of Shmt2. Functionally, under L-serine poor conditions in vitro and ex vivo, D-serine inhibited the proliferation of immature and undifferentiated neural cells including glioblastoma stem cells, which depend highly on one-carbon metabolism. Notably, endogenous D-serine levels were low during early neurodevelopment, but increased with maturation, coinciding with a shift in the transcriptional profiles of serine metabolic enzymes at the cellular level. Given that L-serine supports neurodevelopment and D-serine modulates neurotransmission, this developmental shift in serine enantiomer metabolism appears to align with the functional transitions of the maturing nervous system. Thus, our findings reveal that serine chirality can influence mitochondrial substrate availability and one-carbon flux, offering previously unappreciated insight into the stereoselective regulation of cellular metabolism.</p>
</abstract>
<funding-group>
<award-group id="funding-1">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/00hhkn466</institution-id>
<institution>Japan Society for the Promotion of Science</institution>
</institution-wrap>
</funding-source>
<award-id>15K19497</award-id>
</award-group>
<award-group id="funding-1a">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/00hhkn466</institution-id>
<institution>Japan Society for the Promotion of Science</institution>
</institution-wrap>
</funding-source>
<award-id>17J10213</award-id>
</award-group>
<award-group id="funding-1b">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/00hhkn466</institution-id>
<institution>Japan Society for the Promotion of Science</institution>
</institution-wrap>
</funding-source>
<award-id>22K19408</award-id>
</award-group>
<award-group id="funding-2">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/02kn6nx58</institution-id>
<institution>Keio University</institution>
</institution-wrap>
</funding-source>
<award-id>Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research</award-id>
</award-group>
<award-group id="funding-3">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/02kn6nx58</institution-id>
<institution>Keio University</institution>
</institution-wrap>
</funding-source>
<award-id>Keio Program for the Promotion of Next Generation Research Projects Type A</award-id>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta specific-use="meta-only">
<meta-name>publishing-route</meta-name>
<meta-value>prc</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<fn-group content-type="summary-of-updates">
<title>Summary of Updates:</title>
<fn fn-type="update"><p>This revision is to upload supplemental files and videos, and to match the preprint accepted by eLife.</p></fn>
</fn-group>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Serine is a unique amino acid, both L- and D-enantiomers of which are synthesized <italic>de novo</italic> in the central nervous system. L-serine is primarily synthesized from a glycolytic intermediate through the phosphorylated pathway, and further stereo-converted to D-serine (<xref rid="fig1" ref-type="fig">Fig. 1a</xref>). Serine enantiomers and their metabolites are critically involved in neural development and neurophysiology in three major ways. First, L-serine is a crucial carbon donor with the cofactor, folate for the one-carbon metabolism, which is a universal metabolic process for nucleic acid synthesis, methylation, and reductive metabolism. As these pathways essentially support proliferative cells, undifferentiated or cancer cells are particularly susceptible to deprivation of L-serine or inhibition of <italic>de novo</italic> L-serine synthesis(<xref ref-type="bibr" rid="c18">Geeraerts et al., 2021</xref>). Second, biosynthesis of membrane lipids requires L-serine as an integral component of sphingolipids and phosphatidylserine. The nervous system includes highly polarized neurons and glia, and has the highest lipid content/complexity in the mammalian body. Among membrane lipids, sphingolipids are particularly abundant in the nervous system and are essential for neuronal differentiation, polarization, synapse formation, and myelination, which are required for development and functional integrity of the nervous system(<xref ref-type="bibr" rid="c23">Hirabayashi and Furuya, 2008</xref>). Third, L-serine serves as a precursor for neurotransmitters, such as glycine and D-serine. L-serine is converted to glycine by serine hydroxymethyltransferase (Shmt) in the one-carbon metabolic pathway, and also into D-serine by serine racemase (Srr). Both glycine and D-serine bind physiologically, albeit with different affinities, to the obligatory (GluN1) and regulatory (GluN3) subunits of <italic>N</italic>-methyl-D-aspartate (NMDA) receptors, which regulate excitatory neurotransmission and are crucial in development and functions of the central nervous system(<xref ref-type="bibr" rid="c10">Chatterton et al., 2002</xref>; <xref ref-type="bibr" rid="c49">Nancy and Dingledine, 1988</xref>). In addition, glycine also binds to inhibitory glycine receptors and controls early embryonic development as well as a variety of motor and sensory functions(<xref ref-type="bibr" rid="c39">Lynch, 2004</xref>).</p>
<fig id="fig1" position="float" fig-type="figure">
<label>Fig. 1.</label>
<caption><title>D-serine inhibits one-carbon metabolism</title>
<p><bold>A</bold>. A heatmap shows top 25 metabolites in PCNs altered by treatment with D- and/or L-serine in the metabolomic analysis (n = 3). <bold>B</bold>. Major metabolites in the one-carbon metabolism. <bold>C</bold>. KEGG metabolic pathways enriched in D-serine treated cells compared to vehicle treated cells. <bold>D</bold>. Pearson’s correlation coefficients between glycine and other metabolites. Top 25 metabolites positively (red) and negatively (blue) correlated with glycine are shown. <bold>E, F</bold>. Concentrations of glycine (<bold>E</bold>) and L-serine (<bold>F</bold>) in PCNs were quantified using HPLC (n = 4). <bold>G</bold>. Concentrations of formate in the culture media of PCNs treated with 2 mM D- or L-serine (n = 4). Data are presented as the mean ± s.e.m. (<bold>E, F</bold>, and <bold>G</bold>). Statistical significance was evaluated by one-way ANOVA followed by Dunnett’s post hoc-test (<bold>E, F</bold>, and <bold>G</bold>). *<italic>p</italic> &lt; 0.05 (<bold>A</bold>). Data are the representative of two independent experiments.</p></caption>
<graphic xlink:href="610855v3_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Defects of L-serine synthesis due to single nucleotide polymorphisms in the genes encoding 3-phosphoglycerate dehydrogenase (PHGDH), the rate-limiting enzyme in the phosphorylated pathway, or the downstream enzyme phosphoserine aminotransferase (PSAT1) are associated with congenital microcephaly and hypomyelination, and exhibit psychomotor retardation and seizures in humans (<xref ref-type="bibr" rid="c28">Jaeken et al., 1997</xref>; <xref ref-type="bibr" rid="c32">KONING et al., 2002</xref>). Phgdh deficient mice die in embryo after 13.5 days post-coitum and show systemic growth defects, especially severe hypoplasia of the central nervous system, with marked reductions of L-serine and sphingolipids(<xref ref-type="bibr" rid="c70">Yoshida et al., 2004</xref>). Indeed, proliferative-marker-positive cells and mature neurons are almost entirely absent in these mice, indicating that <italic>de novo</italic> biosynthesis of L-serine is critical for neuronal proliferation and differentiation. Given that L-serine synthesis impacts diverse metabolites in one-carbon metabolism, lipid synthesis, and neurotransmitters glycine and D-serine(<xref ref-type="bibr" rid="c69">Yang et al., 2010</xref>), L-serine likely serves multiple functions in neural development. Of note, serine synthesis shows drastic changes after neurogenesis. Neural progenitor cells (NPCs) express PHGDH, whereas mature neurons lack its expression and lose the ability to synthesize L-serine. In mature neural tissue, on the other hand, astrocytes take over L-serine synthesis, and supply neurons with L-serine for synthesis of neurotransmitter D-serine(<xref ref-type="bibr" rid="c67">Wolosker, 2011</xref>). This metabolic compartmentalization suggests that D- and L-serine serve distinct functions tailored to the metabolic demands of specific neural cell types and developmental stages. However, how D-serine contributes to cellular metabolism beyond neurotransmission remains largely unknown.</p>
<p>In this study, we employed a metabolomics-based approach to examine how D-serine affects cellular metabolism, identified its primary target pathway in vitro, and assessed the functional consequences in neural cells both in vitro and ex vivo systems.</p>
</sec>
<sec id="s2">
<title>Main</title>
<sec id="s2a">
<title>D-serine impacts metabolites in one-carbon metabolism</title>
<p>To test whether serine chirality influences cellular metabolism in neural tissue, we compared metabolomic profiles of primary cultured neurons (PCNs) treated with or without L-or D-serine. Serine enantiomers markedly altered the levels of metabolites such as glycine, cysteine, hypotaurine, taurine, glutathione, AMP, uracil, and polyamines (<xref rid="fig1" ref-type="fig">Fig. 1A</xref> and Fig. S1A and B). These metabolites are components of the one-carbon metabolic network, including the folate cycle and synthetic pathways for purine, glutathione, taurine, and polyamine (<xref rid="fig1" ref-type="fig">Fig. 1B</xref>), all of which are initiated by one-carbon donation from L-serine. Compared to D-serine, L-serine affected a broader range of metabolic pathways, including several amino acid metabolism (<xref rid="fig1" ref-type="fig">Fig. 1C</xref> and Fig. S1C). Notably, however, D-serine uniquely caused a marked reduction in glycine levels (<xref rid="fig1" ref-type="fig">Fig. 1A</xref>), which was further confirmed using a two-dimensional HPLC system (2D HPLC), a highly sensitive tool to quantify enantiomers, to occur independently of any change in L-serine levels (<xref rid="fig1" ref-type="fig">Fig. 1E</xref> and F). Metabolites that showed similar reduction patterns to glycine were primarily polyamines and their intermediates (<xref rid="fig1" ref-type="fig">Fig. 1D</xref>). Given that glycine is synthesized in the initial step of the one-carbon pathway, and that polyamines are produced in a downstream branch of the one-carbon network (<xref rid="fig1" ref-type="fig">Fig. 1B</xref>), these results suggest that D-serine broadly suppresses one-carbon metabolism. In support of our view, D-serine treatment on PCNs further reduced production of formate, an intermediate of the folate cycle in one-carbon metabolism, whereas L-serine enhanced it (<xref rid="fig1" ref-type="fig">Fig. 1G</xref>). Therefore, these findings indicate that D-serine exerts an inhibitory effect on the one-carbon metabolism, in contrast to the supportive role of L-serine.</p>
</sec>
<sec id="s2b">
<title>D-serine suppresses one-carbon flux by competing with L-serine transport to mitochondria</title>
<p>In the central nervous system, glycine is synthesized from L-serine by serine hydroxymethyltransferase (Shmt) 1 and 2 (<xref rid="fig2" ref-type="fig">Fig. 2A</xref>), which performs the first transfer of a carbon unit from L-serine to folate in one-carbon metabolism (<xref ref-type="bibr" rid="c54">Pan et al., 2020</xref>). In the presence of mitochondrial Shmt2, transfer of a carbon unit from L-serine to tetrahydrofolate (THF) and glycine production depends primarily on mitochondrial enzyme, but not cytoplasmic Shmt1 (<xref rid="fig2" ref-type="fig">Fig. 2A</xref>)(<xref ref-type="bibr" rid="c13">Ducker et al., 2016</xref>). Therefore, the molecular target of D-serine in its inhibition of the initial step of one-carbon metabolism is likely mitochondrial Shmt2 or supply of its substrates into mitochondria (<xref rid="fig2" ref-type="fig">Fig. 2A</xref>). To study whether D-serine impacts catalytic activity of Shmt2, we compared homotetrameric assembly of human SHMT2 combined with either L- or D-serine in the presence of THF and pyridoxal phosphate (PLP) (Fig. S2). When L- or D- serine was placed in the binding pocket of Shmt2, the eliminating carbon in D-serine was more distant from phosphorus (P) and oxygen (O) in PLP by 1.50 Å (C-P) and 1.10 Å (C-O) than that in L-serine (<xref rid="fig2" ref-type="fig">Fig. 2B</xref> and Fig. S2A and B), suggesting that D-serine is not a good substrate for SHMT2. To investigate the stability of serine enantiomers in the binding pocket, we further performed molecular dynamic (MD) simulation of the serine-bound SHMT2 complex systems. MD simulation indicated that binding of D-serine did not affect the overall structure of SHMT2 compared to that of L-serine (Fig. S2C). On the other hand, molecular interactions of D-serine with SHMT2 were unstable and D-serine could not stay in the serine-binding pocket of SHMT2 (<xref rid="fig2" ref-type="fig">Fig. 2C</xref> and Supplementary video 1), which is supported by a recent report that SHMT does not use D-serine as a substrate in the canonical hydroxymethyl-transferase reaction in one-carbon metabolism(<xref ref-type="bibr" rid="c44">Miyamoto et al., 2024</xref>). In contrast, L-serine remained placed stably in the pocket (<xref rid="fig2" ref-type="fig">Fig. 2C</xref> and Supplementary video 2). Therefore, D-serine was unlikely to compete with L-serine binding to SHMT2. Indeed, an <italic>in vitro</italic> experiment using recombinant SHMT2 showed that D-serine did not affect conversion of L-serine to glycine (<xref rid="fig2" ref-type="fig">Fig. 2D</xref>).</p>
<fig id="fig2" position="float" fig-type="figure">
<label>Fig. 2.</label>
<caption><title>D-serine inhibits cytoplasmic L-serine transport to mitochondria</title>
<p><bold>A</bold>. L-serine/glycine transport and conversion across cytoplasm and mitochondria in one-carbon metabolism. <bold>B</bold>. Binding sites of D- (right) or L-serine (left), THF, and pyridoxal phosphate (PLP) in the ligand-bound SHMT2 complex systems. Arrows indicate carbon atoms on serine enantiomers that transfer to THF. <bold>C</bold>. Time series variation of the number of contact atoms within the distance cutoff of 7.0 Å from D- or L-serine observed at the initial structure. <bold>D</bold>. SHMT2 enzymatic activity determined by glycine production is shown as percent of control (with no D-serine) (n = 3). <bold>E</bold>. Relative concentrations of glycine in NPCs treated with or without 2mM D-serine and/or 50 μM THF. <bold>F</bold>. Inhibition of mitochondrial L-serine transport by D-serine was examined in semi-permeabilized cells (n = 4). <bold>G</bold>. A PCA plot shows RNA-seq results from cells treated with D-serine (pink) or control (gray). <bold>H</bold>. A volcano plot indicates differentially expressed genes in cells treated with D-serine vs controls. Gene expressions with adjusted <italic>p</italic>-values &lt; 0.05 are highlighted in yellow (up) or blue (down). <bold>I</bold>. Bar plots show Normalized Enrichment Score for the top 10 up or down-regulated GSEA-enriched categories. Color, q-value. <bold>J</bold>. GSEA plots for a core subset of gene ontologies are displayed. Data are plotted as the mean ± s.e.m. (<bold>D, E</bold>, and <bold>F</bold>). Statistical significance was evaluated by one-way ANOVA followed by Tukey’s post hoc-test (<bold>D</bold>) or Dunnett’s post hoc-test (<bold>E</bold>).</p></caption>
<graphic xlink:href="610855v3_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Next, we wondered whether D-serine inhibits supply of Shmt2 substrate(s), L-serine or THF, to mitochondria. Since reduction of glycine caused by D-serine in PCNs was compensated by addition of L-serine, but not of THF (<xref rid="fig1" ref-type="fig">Fig. 1E, 2E</xref>), we assumed that L-serine supply to mitochondria is disturbed by D-serine. Moreover, in PCNs, endogenous L-serine synthesis was not disturbed by addition of D-serine (<xref rid="fig1" ref-type="fig">Fig. 1F</xref>), suggesting that D-serine affects L-serine transport to mitochondria, but not its synthesis. To confirm that D-serine impacts L-serine transport to mitochondria, we semi-permeabilized a neuroblastoma cell line, Neuro2a, to loosen cell membranes and monitored [H<sup>3</sup>]L-serine transport into mitochondria and other organelles in the presence or absence of D-serine. Intriguingly, D-serine competitively inhibited transport of L-serine in a dose-dependent manner (IC50, 1.604 mM) (<xref rid="fig2" ref-type="fig">Fig. 2F</xref>). Thus, these results suggested that D-serine impairs one-carbon metabolism by competing with L-serine transport to mitochondria, but not by direct inhibition of Shmt2 activity.</p>
<p>To further understand the overall cellular responses to the D-serine burden, we performed RNA-sequencing using Neuro2a cells treated with D-serine. D-serine mildly, but significantly altered the transcriptome profile compared with vehicle control (<xref rid="fig2" ref-type="fig">Fig. 2G</xref> and <xref ref-type="fig" rid="fig2">H</xref>). There were 685 up-regulated genes (log<sub>2</sub> fold-change &gt; 0, adjusted p-value &lt; 0.05) and 905 down-regulated genes (log<sub>2</sub>-fold change &lt; 0, adjusted p-value &lt; 0.05) (<xref rid="fig2" ref-type="fig">Fig. 2H</xref>). To determine whether genes with significant alterations are clustered in specific functional gene sets, we performed gene set enrichment analysis. Notably, D-serine enhanced expressions of genes associated with mitochondrial functions, such as respiratory chain complex assembly, ATP synthesis driven by proton motive force, and mitochondrial gene expression / translation. On the other hand, gene sets linked to amino acid import across the plasma membrane, cellular growth, and neuron projection extension were down-regulated (Fig.2I and J and Fig.S3). These dynamic transcriptional changes in the neuroblastoma cell line indicate that D-serine can impact polarization and growth of immature neurons negatively and further indicate that immature neurons resist D-serine-induced cellular stress by enhancing mitochondrial function, including energy synthesis.</p>
</sec>
<sec id="s2c">
<title>D-serine inhibits proliferation of tumor cells</title>
<p>One-carbon metabolism provides essential metabolites for nucleotide synthesis, methylation, and reductive metabolism, and supports cellular proliferation. Tumor cells are highly proliferative and are particularly susceptible to deprivation of one-carbon units by L-serine restriction or inhibition of <italic>de novo</italic> serine synthesis (<xref ref-type="bibr" rid="c50">Newman and Maddocks, 2017</xref>). Given that D-serine inhibits one-carbon flux by competing with L-serine in PCNs and the neuroblastoma cell line, we wondered whether D-serine influences proliferation of neural tumor cells. To test this idea, we treated several human/rodent neuroblastoma cell lines cultured in the regular medium containing sub-millimolar L-serine and fetal bovine serum with D-serine. Consistent with our findings that D-serine competes with L-serine transport (<xref rid="fig2" ref-type="fig">Fig. 2F</xref>), high concentrations of D-serine were required to suppress proliferation of neuroblastoma cell lines cultured in regular medium (Fig. S4A). In contrast, culturing in L-serine/glycine-free medium with dialyzed fetal bovine serum reduced the proliferation of Neuro2a cells with much lower D-serine concentrations (IC50 = 1.94 mM) (Fig. S4B-D), which corresponds to the efficacy of D-serine on inhibition of L-serine transport (IC50 = 1.604 mM) (<xref rid="fig2" ref-type="fig">Fig. 2F</xref>). Indeed, with L-serine/glycine-free medium, D-serine significantly inhibited proliferation of all neuroblastoma cell lines tested, at low millimolar concentrations (<xref rid="fig3" ref-type="fig">Fig. 3A</xref>). In accordance with its effect on PCNs (<xref rid="fig1" ref-type="fig">Fig. 1E</xref>), D-serine inhibited production of glycine and suppressed proliferation of Neuro2a cells, which was rescued by supplementation with L-serine (<xref rid="fig3" ref-type="fig">Fig. 3B</xref> and Fig. S4E). Moreover, supplementations with glycine and downstream metabolites of the folate cycle in the one-carbon pathway (<xref rid="fig1" ref-type="fig">Fig. 1B</xref>), such as formate, inosine monophosphate (IMP), or 5,10-meTHF, phenocopied the rescue effect by L-serine (Fig. S4E-I). On the other hand, combinations of glycine and metabolites of the methionine cycle (methionine or methylcobalamin (meCbl)) as well as other metabolites associated with one-carbon metabolism (thymidine monophosphate (dTMP) or glutathione) (<xref rid="fig1" ref-type="fig">Fig. 1B</xref>) failed to liberate cells (Fig. S4J and K). These results suggest that D-serine impacts the folate cycle rather than the methionine cycle in one-carbon metabolism to prevent growth of neuroblastoma cells.</p>
<fig id="fig3" position="float" fig-type="figure">
<label>Fig. 3.</label>
<caption><title>D-serine attenuates proliferation of neural tumor cells</title>
<p><bold>A, C, H</bold>. Relative proliferation of neuroblastoma cell lines (<bold>A</bold>), glioblastoma lines (<bold>C</bold>), and glioma stem cells (<bold>H</bold>) treated with D-serine at indicated doses were analyzed 48 h after treatment (n = 4, each). Cells with the vehicle treatment were used as 100% proliferation controls. <bold>B</bold>. Glycine concentration in Neuro2a cells was quantified 48 h after treatment with D- and/or L-serine (n = 3). <bold>D, E</bold>. Cell proliferation was assessed 48 h after treatment with 5 mM D-serine and formate/folates at indicated doses (n = 4). Cell proliferation was compared to that of cells treated with D-serine alone. <bold>F, G, J, K</bold>. <italic>Ex vivo</italic> slice cultures of mouse brain transplanted with U87 (<bold>F, G</bold>) or hG008 cells (<bold>J, K</bold>) expressing Venus fluorescence were treated with D-serine. Representative images of the xenograft at 0 and 7 days after treatment are shown (<bold>F, J</bold>). Increased area of fluorescence after 7 days of culture was measured (<bold>G, K</bold>). <bold>I</bold>. Sphere diameters of glioma stem cells (hG008) were measured at 7 days after treatment with D-serine at indicated doses. Data are presented as the mean ± s.e.m. (<bold>A-E, G-I</bold>, and <bold>K</bold>). Statistical significance was evaluated by one-way ANOVA followed by Dunnett’s post-hoc test (<bold>B, D</bold>, and <bold>E</bold>) or by Student’s t-test (<bold>G</bold> and <bold>K</bold>).</p></caption>
<graphic xlink:href="610855v3_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>As neurons and astroglia share a common developmental origin, we further tested whether glial tumor cells also show vulnerability to D-serine. Glioblastoma is the most common malignant brain tumor in adults, whose survival rate is low despite advances in surgical and medical neuro-oncology(<xref ref-type="bibr" rid="c8">Bent et al., 2023</xref>; <xref ref-type="bibr" rid="c12">Delgado-López and Corrales-García, 2016</xref>). Among human glioblastoma cell lines (U87, U251, SF126), U251 cells were the most sensitive to D-serine treatment (<xref rid="fig3" ref-type="fig">Fig. 3C</xref>). Supplementation with glycine and formate restored proliferation of U251 (<xref rid="fig3" ref-type="fig">Fig. 3D</xref>), and 5,10-meTHF recovered the vulnerability to D-serine, albeit very mildly (<xref rid="fig3" ref-type="fig">Fig. 3E</xref>), supporting the significance of one-carbon metabolism in growth of glioblastoma cell lines too. To further test the anti-proliferative effect of D-serine in the tumor microenvironment, we made an organotypic brain slice culture from mice with orthotopic xenografts of glioblastoma cells expressing Venus fluorescence(<xref ref-type="bibr" rid="c62">Tamura et al., 2019</xref>). Brain slices of mice implanted with U87 cells in the striatum were cultured <italic>ex vivo</italic> for 7 days in serine/glycine-free media containing D-serine or vehicle. D-serine strikingly suppressed expansion of U87 cells with Venus fluorescence compared to the control treatment, even in <italic>ex vivo</italic> tumor culture (<xref rid="fig3" ref-type="fig">Fig. 3F</xref> and <xref ref-type="fig" rid="fig3">G</xref>). Since glioma stem cells (GSCs) in the glioblastoma have self-renewal and tumor-initiating capacity and cause cancer recurrence(<xref ref-type="bibr" rid="c19">Gimple et al., 2022</xref>; <xref ref-type="bibr" rid="c63">Tang et al., 2021</xref>), we wondered whether GSCs also have similar vulnerability to D-serine. <italic>In vitro</italic>, D-serine reduced viability of cell lines for GSCs (hG008 and hG020), established from human glioblastoma specimens<sup>25</sup>, in a dose-dependent manner with greater efficacy to the hG008 line (<xref rid="fig3" ref-type="fig">Fig. 3H</xref>). This growth defect in hG008 cells induced by D-serine was rescued by supplementation with glycine and formate, as in neuroblastoma and glioblastoma cells (Fig. S4L). hG008 cells have a sphere-forming capacity<sup>23</sup>, and we also observed D-serine-induced reduction of sphere diameters of hG008 cells cultured under the sphere-forming conditions (<xref rid="fig3" ref-type="fig">Fig. 3I</xref>). Moreover, in brain slices of mice with orthotopic xenografts of hG008 cells expressing Venus fluorescence, D-serine significantly inhibited growth and invasiveness of hG008 cells (<xref rid="fig3" ref-type="fig">Fig. 3J</xref> and K). Thus, brain tumor cells showed consistent vulnerability to D-serine via inhibition of one-carbon metabolism.</p>
</sec>
<sec id="s2d">
<title>D-serine induces apoptosis by interfering with one-carbon metabolism in neuroprogenitor cells</title>
<p>Neural stem cells have similar characteristics to neural tumor cells with high proliferative capacity(<xref ref-type="bibr" rid="c57">Reya et al., 2001</xref>). To test whether D-serine also affects immature neurons, we made a primary culture of neuroprogenitor cells (NPCs) from telencephalon in E14 mice in serine-free Neurobasal medium, treated with D- or L-serine from DIV1. At DIV7, L-serine treatment significantly increased the number of neurons with a condensed neurites compared to vehicle-treated neurons. In contrast, D-serine-treated culture had fewer number of neurons with sparse neurites, suggesting that D-serine has a negative impact on maturation of NPCs (<xref rid="fig4" ref-type="fig">Fig. 4A</xref>). Furthermore, D-serine activated cleavage of caspase-3 dose-dependently in Nestin-positive NPCs and Tubb3+ developing neurons 48 h after treatment, whereas L-serine had no effect (<xref rid="fig4" ref-type="fig">Fig. 4B-D</xref>, Fig. S5A-C). In contrast, vesicular glutamate transporter 2 (vGlut2)-positive mature excitatory neurons, glutamate decarboxylase-67 (Gad67)-positive mature inhibitory neurons, and glial fibrillary acidic protein (Gfap)-positive glial cells did not undergo apoptosis under D- or L-serine treatment (<xref rid="fig4" ref-type="fig">Fig. 4B</xref> and Fig. S5D and E), suggesting that mature neurons and astrocytes are resistant to D-serine. Consistently, D-serine treatment at DIV7 did not activate cleavage of caspase-3 or reduce proliferation of neurons (<xref rid="fig4" ref-type="fig">Fig. 4E</xref> and <xref ref-type="fig" rid="fig4">F</xref>). Susceptibility of NPCs was pronounced in the presence of D-serine, but was not caused by other D-amino acids, such as D-aspartate, D-alanine, or D-proline (Fig. S6A), which can be detected in mammalian intestinal bacteria(<xref ref-type="bibr" rid="c21">Gonda et al., 2023</xref>). As D-serine is a coagonist of NMDA receptors(<xref ref-type="bibr" rid="c46">Mothet et al., 2000</xref>; <xref ref-type="bibr" rid="c68">Wolosker and Balu, 2020</xref>), we further tested whether D-serine neurotoxicity involves NMDA receptors(<xref ref-type="bibr" rid="c42">McNamara and Dingledine, 1990</xref>). Blockade of Ca<sup>2+</sup> influx through NMDA receptors by a non-competitive NMDA antagonist, MK-801, or of D-serine-binding to the receptors by 5,7-dichlorokynurenic acid (DCKA) did not attenuate D-serine neurotoxicity (Fig. S6B and C). Also, inhibition of the receptor’s downstream signal by <italic>N</italic>-nitro-L-arginine methylester (L-NAME) or an antioxidant (glutathione) did not affect enhanced cleavage of caspase-3 by D-serine (Fig. S6D and E). Thus, our findings suggest that apoptosis triggered by D-serine in NPCs does not mediate NMDA receptors. To test whether apoptosis triggered by D-serine involves amino acid metabolism, we supplemented NPCs treated with D-serine from DIV1 with various L-amino acids or glycine. As expected, among L-amino acids and glycine, L-serine specifically and dose-dependently inhibited cleavage of caspase-3 caused by D-serine (<xref rid="fig4" ref-type="fig">Fig. 4G</xref> and <xref ref-type="fig" rid="fig4">H</xref>), which is consistent with competitive mitochondrial transport of serine enantiomers (<xref rid="fig2" ref-type="fig">Fig. 2F</xref>). Moreover, similar to the observation that 5,10-methylene THF rescued neural tumor cell growth (Fig. S4I), 5,10-methylene THF restored D-serine-induced cleavage of caspase-3 in NPCs (<xref rid="fig4" ref-type="fig">Fig. 4I</xref>), suggesting that D-serine interferes with L-serine functions, such as its role in one-carbon metabolism.</p>
<fig id="fig4" position="float" fig-type="figure">
<label>Fig. 4.</label>
<caption><title>Developmental transition of serine enantiomer synthesis and enantio-selective effects on immature and mature neurons</title>
<p><bold>A</bold>. Light microscopic view showing primary cultured NPCs treated with 1mM D- or L-serine for 7 days in serine-free media. <bold>B</bold>. Immunofluorescent images are NPCs treated with 1 mM D-serine for 48 hours. Cleaved caspase-3 (c-Casp-3), green (left) or red (right); βIII Tubulin, red (left); GAD67, green (right); and DAPI (blue). <bold>C</bold>. Numbers of NPCs per area at DIV7 in (<bold>A</bold>) were counted (n = 4). <bold>D</bold>. Western blots indicate cleavage of caspase-3 in cultured neurons at 48 h after treatment of D-serine with indicated doses. <bold>E</bold>. Western blots indicate cleavage of caspase-3 in cultured neurons at 48 h after treatment of serine enantiomers with indicated doses starting at DIV1 (immature) or DIV7 (mature neurons or astrocytes). <bold>F</bold>. Relative cell proliferation of NPCs after 48 h treatment of 1mM serine enantiomers was analyzed (n = 4). <bold>G. H</bold>. Cleavage of caspase-3 in NPCs induced by 1mM D-serine was observed in the presence of various L-amino acids (1 mM each) (<bold>G</bold>) or L-serine at indicated doses (<bold>H</bold>). <bold>I</bold>. Cleavage of caspase-3 in NPCs triggered by 2 mM D-serine was observed in the presence or absence of 40 μM 5,10-meTHF. <bold>J</bold>. Concentrations of serine enantiomers and glycine and the ratio of serine enantiomer concentrations in the cerebrum during development (n= 3-4). <bold>K</bold>. Single-cell transcriptome profiles of enzymes involved in serine metabolic pathways during mouse brain development. Original data were from Bella et al(<xref ref-type="bibr" rid="c7">Bella et al., 2021</xref>). Data are plotted as the mean ± s.e.m. Statistical significance was evaluated by One-way ANOVA followed by Dunnett’s post hoc test (<bold>C</bold>). All <italic>in vitro</italic> data are the representative of at least two independent experiments.</p></caption>
<graphic xlink:href="610855v3_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>To further rule out alternative mechanisms, we examined whether D-serine disrupts L-serine-mediated lipid synthesis. During the neuronal development, NPCs require L-serine to synthesize membrane sphingolipids and phospholipids that support cellular expansion and neurite elongation (Fig. S7A). A comparative lipidomic study using NPCs revealed that D-serine treatment increased phosphatidylserine, but not sphingolipids or other phospholipids (Fig. S7B and C). To test whether D-serine is incorporated into phosphatidylserine, we extracted membrane lipids, hydrolyzed phosphatidylserine using phospholipase D (PLD) to release serine, and quantified serine enantiomers using 2D HPLC (Fig. S7D and E). Phosphatidylserine extracted from NPCs cultured without D-serine harbored only L-serine, but supplementation with D-serine significantly increased phosphatidyl-D-serine and decreased phosphatidyl-L-serine (Fig. S7F). This effect was abolished by co-supplementation with L-serine (Fig. S7F). However, exogenous phosphatidyl-L-serine failed to rescue D-serine-induced apoptosis (Fig. S7G), indicating that composition of membrane phosphatidyl-serine is not the primary cause of cell death. Together, these results demonstrate that D-serine impairs the survival of immature neural cells not by modulating neurotransmission or lipid metabolism, but by disrupting one-carbon metabolism through competition with L-serine.</p>
</sec>
<sec id="s2e">
<title>Enantiomeric shift of serine metabolism during neural development</title>
<p>Serine metabolism is fundamental to multiple cellular functions and crucial for neural development. To gain a functional overview of how serine chirality contributes to these processes, we monitored serine enantiomers and glycine using the 2D HPLC system. L-serine levels in the mouse cerebral cortex showed a gradual increase during embryonic development, dropped at birth, and remained at a concentration above 500 nmol/g thereafter (<xref rid="fig4" ref-type="fig">Fig. 4J</xref>). As glycine synthesis depends in part on L-serine, glycine showed a similar trend to L-serine in embryo and maintained levels above 800 nmol/g after birth (Fig.4J). On the other hand, D-serine was trace during the embryonic stage, but increased gradually after birth. Therefore, the D/L-serine ratio exhibited a steady increase after birth and reached 0.4 in mature mouse brain (<xref rid="fig4" ref-type="fig">Fig. 4J</xref>). The dynamics of serine enantiomers during the brain development is corroborated by transcriptional profiles associated with serine chial metabolism. Bulk RNA-seq data of developing neurons derived from mouse embryonic stem cells (ESC)(<xref ref-type="bibr" rid="c25">Hubbard et al., 2013</xref>) or human inducible pluripotent stem cells (iPSC)(<xref ref-type="bibr" rid="c9">Burke et al., 2020</xref>) in public databases showed that diverse transcriptions found in the phosphorylated pathway of L-serine synthesis (PHGDH, PSAT1, and PSPH), one-carbon metabolism (SHMT1/2, MTHFD1/2, and MTHFD1/2L), and nucleic acid synthetic pathway (DHFR, TYMS, MTHFS) decrease along with the neuronal maturation (Fig. S8A and B). In contrast, D-serine-synthetic enzyme SRR increases after days <italic>in vitro</italic> 7 (DIV7) in ESC-derived neurons and NPC/Rosetta cells (DIV14-21) in human iPSC-derived neurons. Subunits of NMDA receptors, including Grin1/GluN1, to which D-serine or glycine binds, are expressed in matured neurons after DIV16 of mouse ESC-derived cells (Fig. S8A) or those at DIV49 of human iPSC-derived cells (Fig. S8B). Alterations of serine metabolism during development were further supported by single-cell RNA-seq performed by Bella et al.(<xref ref-type="bibr" rid="c7">Bella et al., 2021</xref>), which provides crucial information about the trajectory of differentiating cells and cell type-specific transcriptional profiles during mouse brain development <italic>in vivo</italic>. Uniform manifold approximation and projection (UMAP) illustrates that Sox2+ neural progenitor cells (cluster 1, 7, 9, and 11) express L-serine synthetic enzymes (Phgdh, Psat1, Psph) and folate cycle enzymes (Tyms, Mthfd1, Dhfr) as well as a proliferation marker gene Mki67 (<xref rid="fig4" ref-type="fig">Fig. 4K</xref> and Fig. S8C and D). Apoe+ and Aldh1l1+ astrocytes (cluster 7) also express L-serine synthetic pathways, whereas Tubb3+ mature neurons (cluster 0, 2, 3, 4, 5, 8, 12, 13, 15, 16, 19, 22) do not express serine synthetic enzymes (<xref rid="fig4" ref-type="fig">Fig. 4K</xref> and Fig. S8C and D). Tubb3+ neurons weakly express Srr at P4 but not E10 (Fig. S8E). These transcriptional profiles suggest that reduction of L-serine biosynthesis during neural development accompanies inactivation of the folate cycle and one-carbon metabolism, and that mature neurons start to synthesize D-serine. Given that the folate cycle and one-carbon metabolism, essential for nucleic acid biosynthesis, are the metabolic signature of cell proliferation, NPCs lose their metabolic activity for proliferation in the embryonic stage but instead develop the capacity for neurotransmission during the postnatal development. Although we found that D-serine inhibits L-serine-dependent one-carbon metabolism, its endogenous production is minimal in neural stem/progenitor cells and increases only after the onset of neuronal maturation, coinciding with the upregulation of Srr. Thus, D-serine is unlikely to play a direct role in regulating proliferative metabolism during early neurodevelopment. Rather, its selective synthesis in post mitotic neurons appears metabolically rational, aligning with their shift from proliferation to neurotransmission.</p>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>We found that D-serine competes with mitochondrial transport of L-serine, thereby limiting substrate availability for Shmt2 and suppressing one-carbon metabolic flux. This metabolic interference leads to reduction of glycine and formate, as well as downregulation of downstream pathways including polyamine synthesis. Functionally, under L-serine limited conditions, D-serine suppresses the proliferation and survival of immature neural cells, independent of NMDA receptor activation. Moreover, we demonstrated that endogenous D-serine production increases postnatally in tandem with neuronal maturation, whereas early progenitor cells remain devoid of D-serine synthetic enzyme. These findings highlight a previously unrecognized, stereoselective regulation of cellular metabolism by D-serine, and provide a rationale for its selective synthesis in mature neurons where proliferative metabolic activity is no longer required.</p>
<p>In the central nervous system, L-serine increases during fetal development and declines rapidly after birth, while D-serine increases only after birth and reaches the mature levels within a few weeks (<xref rid="fig4" ref-type="fig">Fig. 4J</xref>). This postnatal increase of D-serine is consistent with a previous report in rats(<xref ref-type="bibr" rid="c22">Hashimoto et al., 1993</xref>) and can be explained by a gradual increase of Srr after birth in mouse glutamatergic neurons (Fig. S8A and E) or forebrain tissue(<xref ref-type="bibr" rid="c43">Miya et al., 2008</xref>). In the mature brain, the majority of Srr is restricted to neurons(<xref ref-type="bibr" rid="c4">Balu et al., 2014</xref>; <xref ref-type="bibr" rid="c43">Miya et al., 2008</xref>), which coincides with our view that D-serine synthesis is a sign of neuronal maturation. In contrast, PHGDH is not expressed in neurons, but is confined to astrocytes in mature brain(<xref ref-type="bibr" rid="c69">Yang et al., 2010</xref>). This astrocyte-specific expression of the L-serine synthetic enzyme accords with our findings that a set of genes encoding enzymes for L-serine synthesis and one-carbon metabolism are downregulated in mature neurons, but confined to a cell population with mature astrocyte markers (<xref rid="fig4" ref-type="fig">Fig. 4K</xref> and S8). Given that astrocytes require one-carbon metabolism for proliferation and that neurons prioritize neurotransmission, such cell-type specific and enantio-selective serine metabolism in the matured brain appears to be a reasonable metabolic compartmentalization. Indeed, loss of D-serine synthesis does not trigger developmental abnormalities(<xref ref-type="bibr" rid="c43">Miya et al., 2008</xref>), but causes functional or structural abnormalities in mature neurons(<xref ref-type="bibr" rid="c3">Balu et al., 2012</xref>; <xref ref-type="bibr" rid="c5">Basu et al., 2009</xref>; <xref ref-type="bibr" rid="c24">Horn et al., 2017</xref>; <xref ref-type="bibr" rid="c60">Sultan et al., 2015</xref>). Furthermore, supplementation with D-serine in the neonatal brain enhances functional development of forebrain neurons(<xref ref-type="bibr" rid="c52">Nomura et al., 2016</xref>). Therefore, it is likely that D-serine does not promote differentiation of NPCs, but contributes to functional maturation of differentiated neurons.</p>
<p>While D-serine is important for functional maturation of neurons as well as excitatory neurotransmission through NMDA receptors(<xref ref-type="bibr" rid="c5">Basu et al., 2009</xref>; <xref ref-type="bibr" rid="c24">Horn et al., 2017</xref>; <xref ref-type="bibr" rid="c46">Mothet et al., 2000</xref>), D-serine has an inhibitory effect on proliferation and triggers apoptosis in NPCs and other immature cells (<xref rid="fig3" ref-type="fig">Fig. 3</xref> and <xref rid="fig4" ref-type="fig">4</xref>). Extracellular D-serine is a classic trigger of excitotoxicity in neurons(<xref ref-type="bibr" rid="c56">Patel et al., 1990</xref>; <xref ref-type="bibr" rid="c59">Shleper et al., 2005</xref>), whereas it induces intracellularly necrosis/apoptosis in renal tubular cells at high doses(<xref ref-type="bibr" rid="c30">Kaltenbach et al., 1979</xref>; <xref ref-type="bibr" rid="c65">Williams and Lock, 2004</xref>). Excitotoxicity of D-serine has been reported in mature neurons in ischemic or neurodegenerative diseases and mediates NMDA receptors (<xref ref-type="bibr" rid="c26">Inoue et al., 2008</xref>; <xref ref-type="bibr" rid="c47">Mustafa et al., 2010</xref>; <xref ref-type="bibr" rid="c58">Sasabe et al., 2007</xref>; <xref ref-type="bibr" rid="c59">Shleper et al., 2005</xref>). In contrast, the D-serine toxicity, which we observed in neural culture, occurs only in immature neurons, and can be rescued by L-serine or intermediates of the one-carbon metabolism, but not by inhibitors of NMDA receptors or their downstream signals (<xref rid="fig4" ref-type="fig">Fig. 4G-I</xref> and S6). The latter toxicity reported in kidneys mediates hydrogen peroxide generated through degradation of D-serine by a D-serine catabolic enzyme, D-amino acid oxidase, plentiful in kidneys(<xref ref-type="bibr" rid="c41">Maekawa et al., 2005</xref>). Nonetheless, D-amino acid oxidase is not expressed in neurons or in the forebrain(<xref ref-type="bibr" rid="c20">Gonda et al., 2022</xref>). Furthermore, as we could not find protective effects by an antioxidant against D-serine toxicity in immature neurons (Fig. S6E), involvement of oxidative stress by hydrogen peroxide is unlikely. Thus, D-serine toxicity observed in this study does not appear mediated by mechanisms previously reported. Importantly, Okada et al., suggests that renal tubular toxicity by D-serine can be ameliorated by L-serine(<xref ref-type="bibr" rid="c53">Okada et al., 2017</xref>). Although the authors did not demonstrate involvement of one-carbon metabolism in D-serine toxicity in the kidneys, their observation could be associated with our findings that D-serine functionally competes with L-serine (<xref rid="fig4" ref-type="fig">Fig. 4H</xref>).</p>
<p>We show that D-serine attenuates cell proliferation by inhibiting one-carbon metabolism (<xref rid="fig3" ref-type="fig">Fig. 3</xref>). D-serine concentration required to inhibit cell proliferation is greater than physiological concentration (∼300 μM), therefore it is unlikely that physiological level of D-serine determines cell fate. However, it is important to understand that concentration of D-serine increase over the brain development that interferes efficient L-serine metabolic process. Since proliferative cells require one-carbon units for nucleotide synthesis and methylation (<xref rid="fig1" ref-type="fig">Fig. 1B</xref>), one-carbon metabolism is crucial for both developmental and proliferative tissues(<xref ref-type="bibr" rid="c14">Ducker and Rabinowitz, 2017</xref>). As we observe that immature cells are susceptible to D-serine (<xref rid="fig4" ref-type="fig">Fig. 4</xref>), demand for one-carbon units is highest in fetal development(<xref ref-type="bibr" rid="c14">Ducker and Rabinowitz, 2017</xref>). Indeed, in humans, deficiency of L-serine or folate, which receives one-carbon units from L-serine, leads to congenital defects in the central nervous system(<xref ref-type="bibr" rid="c1">Acuna-Hidalgo et al., 2014</xref>; <xref ref-type="bibr" rid="c6">Beaudin and Stover, 2009</xref>). Supply of one-carbon units from L-serine has both cytoplasmic and mitochondrial branches in one-carbon metabolism (<xref rid="fig1" ref-type="fig">Fig. 1B</xref>), but the mitochondrial pathway is critical in embryonic development(<xref ref-type="bibr" rid="c14">Ducker and Rabinowitz, 2017</xref>; <xref ref-type="bibr" rid="c40">MacFarlane et al., 2008</xref>). Therefore, transport of L-serine, generated in the cytoplasm, into mitochondria appears to be a critical step for cellular proliferation during development. A seminal study by Kory et al. has shown that sideroflexin 1, a multipass inner mitochondrial membrane protein, and its homologs mediate L-serine transport to mitochondria(<xref ref-type="bibr" rid="c33">Kory et al., 2018</xref>). Notably, they show <italic>in vitro</italic> that D-serine competes with L-serine transport through sideroflexin 1. Together with our results from an <italic>in vivo</italic> L-serine competition assay (<xref rid="fig2" ref-type="fig">Fig. 2F</xref>), D-serine may compete with general L-serine transport to mitochondria through transporters, such as sideroflexin homologs. In addition, <italic>de novo</italic> serine synthesis and mitochondrial one-carbon pathway are required for the proliferative phenotype in a large variety of human cancers(<xref ref-type="bibr" rid="c29">Jain et al., 2012</xref>; <xref ref-type="bibr" rid="c35">Labuschagne et al., 2014</xref>; <xref ref-type="bibr" rid="c36">Lee et al., 2014</xref>; <xref ref-type="bibr" rid="c38">Lewis et al., 2014</xref>; <xref ref-type="bibr" rid="c51">Nilsson et al., 2014</xref>). Therefore, the broad anti-proliferative effect of D-serine on neural tumor cells (<xref rid="fig3" ref-type="fig">Fig. 3</xref>) supports our idea that D-serine inhibits the mitochondrial one-carbon pathway. Since cancer genetics indicate two pathways not targeted by existing therapies, de novo serine synthesis and mitochondrial one-carbon metabolism(<xref ref-type="bibr" rid="c14">Ducker and Rabinowitz, 2017</xref>; <xref ref-type="bibr" rid="c50">Newman and Maddocks, 2017</xref>), inhibition of L-serine transport to mitochondria, such as by potent D-serine derivatives, to disconnect these two pathways might be a reasonable target for development of cancer therapeutants.</p>
<p>Neuronal metabolism exhibits the unique property of serine isomerization to adapt to functional maturation (<xref rid="fig4" ref-type="fig">Fig. 4</xref>). Consequently, mature cerebrum contains sub-millimolar levels of D-serine, which account for a quarter of total serine in the cerebrum and are about 100-times higher than blood levels(<xref ref-type="bibr" rid="c45">Miyoshi et al., 2009</xref>). This active stereo-conversion of serine in the cerebrum is unique to mammals among vertebrates(<xref ref-type="bibr" rid="c48">Nagata et al., 1994</xref>), implying that neurophysiological functions of D-serine are inseparable from the functional evolution of the cerebrum in higher vertebrates. Indeed, whereas either D-serine or glycine are required to activate NMDA receptors, D-serine binds to the GluN1 subunit of NMDA receptors with higher affinity than does glycine(<xref ref-type="bibr" rid="c16">Furukawa and Gouaux, 2003</xref>) and also has an inhibitory effect on the GluN3 subunit by competing with glycine(<xref ref-type="bibr" rid="c10">Chatterton et al., 2002</xref>). Therefore, extracellular D-serine appears to be evolutionarily important as a neurotransmitter, with different properties than glycine. On the other hand, the inhibitory function of intracellular D-serine against mitochondrial one-carbon metabolism (<xref rid="fig1" ref-type="fig">Fig. 1</xref> and <xref rid="fig2" ref-type="fig">2</xref>) may be an evolutionarily inherited trait from the biological ancestors of mitochondria, bacteria(<xref ref-type="bibr" rid="c2">Archibald, 2015</xref>). Notably, bacteria depend on one-carbon metabolism for their growth, and D-serine attenuates bacterial growth by inhibiting L-serine metabolism(<xref ref-type="bibr" rid="c11">Cosloy and McFall, 1973</xref>). Therefore, bacterial sensitivity to D-serine may reveal a common pathway for inhibition of mitochondrial one-carbon metabolism by D-serine. Given that neurons do not express enzymes for mitochondrial one-carbon metabolism upon maturation (Fig. S8), evolutionary acquisition of neurophysiological functions of D-serine without cytotoxicity may be due to the fact that mature neurons are not proliferative and do not depend on this conserved metabolic feature of mitochondria. While complete understanding of the significance of serine stereo-conversion in the developmental brain will require further studies to illuminate neurogenesis under spatio-temporally controlled D-serine, our findings provide a basis to understand the significance of maintaining serine enantiomer balance in the central nervous system.</p>
</sec>
<sec id="s4">
<title>Materials and methods</title>
<sec id="s4a">
<title>Animals</title>
<p>All animal experiments were approved by the institutional Animal Experiment Committee and conducted in accordance with Institutional Guidelines on Animal Experimentation at Keio University. C57BL/6Jjcl mice were purchased from CLEA Japan (Tokyo, Japan). ICR mice were from Charles River Laboratories (Wilmington, MA, USA). Female BALB/c nude mice (BALB/cSlc-nu/nu) were from Japan SLC (Shizuoka, Japan). Mice were raised in 12 h light and dark cycle with free access to food (CE-2, CLEA Japan) and water in the specific pathogen-free environment.</p>
</sec>
<sec id="s4b">
<title>Antibodies</title>
<p>Rabbit polyclonal antibodies to cleaved caspase-3 (5A1E) and to GAPDH (14C10) were purchased from Cell Signaling Technologies (Danvers, MA, USA). Mouse monoclonal antibodies to GFAP (Z0334), vGLUT2 (8G9.2), and GAD67 (1G10.2) were from Agilent Technologies (Santa Clara, CA, USA), Abcam (Cambridge, UK), and Merck Millipore (Darmstadt, Germany), respectively.</p>
</sec>
<sec id="s4c">
<title>Cell culture and proliferation assay</title>
<p>NPCs and primary cultured astrocytes (PCAs) were prepared as follows. Telencephalon tissues from ICR mice were dissected at the embryonic day 14, treated with papain, and disassembled by pipetting. The cell suspension was passed through a 40-μm filter, centrifuged, and resuspended in a Neurobasal medium without serine (NB-S). NB-S was manufactured by Research Institute for the Functional Peptide (Yamagata, Japan) based on the concentration of each chemicals in Neurobasal media (ThermoFisher: 21103049) described in the technical resources at ThermoFisher. NPCs were cultured in NB-S supplemented with 2% B-27 supplement (ThermoFisher, Waltham, MA, USA), 1% Penicillin-streptomycin solution (ThermoFisher), and 1% GlutaMAX supplement (ThermoFisher). For PCAs, NPCs were differentiated into astrocytes within 7 days by changing the medium to D-MEM (high glucose) (Fujifilm Wako, Tokyo, Japan) supplemented with 10% FBS (A5256701, ThermoFisher) and 1% Penicillin-Streptomycin at 24 h <italic>in vitro</italic>.</p>
<p>Neuroblastoma (Neuro2a, F11, NSC34, and SHSY5Y) and glioma (U87, U251, SF126) cell lines were cultured in MEM supplemented with 10% dialyzed FBS (S-FBS-NL-065, SERENA Europe GmbH, Brandenburg, Germany), 5 mM D-glucose, 65 μM sodium pyruvate, 1 <sub>×</sub> MEM vitamin solution (ThermoFisher), 2 mM L-glutamine, 0.15 mM L-proline, 0.15 mM L-alanine, 0.15 mM L-aspartic acid, 0.15 mM L-glutamic acid, and 0.34 mM L-asparagine (−SG media) as described in Tajan et al.(<xref ref-type="bibr" rid="c61">Tajan et al., 2021</xref>), unless otherwise noted. Proliferation of NPCs, PCAs, and cancer cell lines was analyzed with Cell Counting Kit-8 in accordance with the manufacture’s protocol (Dojindo, Kumamoto, Japan).</p>
</sec>
<sec id="s4d">
<title>Western blot</title>
<p>NPCs were harvested in a lysis buffer [50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 20 mM ethylenediaminetetraacetate (EDTA), 1% TritonX-100, protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO, USA)]. Protein concentration was analyzed with a BCA assay kit (ThermoFisher), and 20-80 µg of protein were subjected to SDS-PAGE. Then, proteins were transferred to the PVDF membranes and blocked with 10% skim milk in PBST. Proteins were detected with anti-cleaved caspase-3 antibody or ant-GAPDH antibody (Cell Signaling Technology, MA, USA), and HRP-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories, PA, USA).</p>
</sec>
<sec id="s4e">
<title>Metabolomics</title>
<p>Cells were washed twice with 10 mL of PBS(−). The PBS(−) was aspirated, and 1 mL of MeOH containing internal standards was added to the dish. The dish was left for 10 min, and a sample solution was obtained and transferred to a tube. For metabolite extraction, the tube was vortexed and subsequently centrifuged at 20,380×g for 10 minutes at 4 °C (MDX-310, TOMY Seiko, Tokyo, Japan). The 150 μL of supernatant was transferred to another tube and dried by centrifugation at 1,600 rpm (366×g) for 90 min at room temperature (VC-96W, Taitec, Saitama, Japan). Then, 10 μL of 90% MeOH were added, 30 μL of H<sub>2</sub>O were added and mixed, and then the tube was centrifuged at 20,380×g for 10 minutes at 4 °C. The 20 μL of supernatant were transferred to a vial and injected into the LC-MS system.</p>
<p>The LC-MS instrument has previously been described in detail(<xref ref-type="bibr" rid="c17">Fuse et al., 2020</xref>). Briefly, an Agilent Technologies 1290 Infinity LC system and a G6230B time-of-flight MS (TOF–MS) (Agilent Technologies, Santa Clara, CA, USA) were used. Each sample was analyzed in positive and negative modes. Conditions for the analysis in positive mode were set as described previously, with slight modification(<xref ref-type="bibr" rid="c64">Tomita et al., 2018</xref>). The temperature of the LC columns was set at 40 °C. For negative mode, the chromatographic separation was performed using an ACQUITY HSS T3 column (2.1 i.d. × 50 mm, 1.8 μm; Waters, Milford, MA, USA) at 30 °C. The mobile phase, consisting of solvent A (0.1% formic acid in water) and solvent B (acetonitrile), was delivered at a flow rate of 0.3 mL/min. In this study, 50–1,200 m/z was used for the MS setting in negative mode.</p>
<p>Data processing from raw LC-MS data to produce a data matrix including metabolite concentration (sample × metabolite) was described previously(<xref ref-type="bibr" rid="c55">Pang et al., 2021</xref>). Data analyses were performed using MetaboAnalyst (ver. 5.0, <ext-link ext-link-type="uri" xlink:href="https://www.metaboanalyst.ca/">https://www.metaboanalyst.ca/</ext-link>)(<xref ref-type="bibr" rid="c55">Pang et al., 2021</xref>) to produce volcano plots and to conduct pathway analysis and pattern searches. Overall data profiles were visualized using MeV TM4 (ver. 4.9.0, <ext-link ext-link-type="uri" xlink:href="https://sourceforge.net/projects/mev-tm4/">https://sourceforge.net/projects/mev-tm4/</ext-link>).</p>
</sec>
<sec id="s4f">
<title>Quantification of glycine and serine enantiomers</title>
<p>Glycine and serine enantiomers in cell-cultured media or brain tissues were measured using two-dimensional HPLC, as previously described(<xref ref-type="bibr" rid="c21">Gonda et al., 2023</xref>; <xref ref-type="bibr" rid="c27">Ishii et al., 2018</xref>). Briefly, samples were mixed with 9 volumes of MeOH and centrifuged to remove protein depositions. Supernatants were spin-dried and resuspended in Milli-Q water. Resuspensions were resuspended in 200 mM sodium borate, and then derivatized with 4-fluoro-7-nitro-2,1,3-benzoxadiazole (NBD-F). NBD-conjugated amino acids were injected into a two-dimensional HPLC system (NANOSPACE SI-2 series, Shiseido, Tokyo, Japan), separated on an octadecylsilyl column (Singularity RP18, 1.0 mm inner diameter (ID) × 250 mm) (designed by Kyushu University and KAGAMI Co. Ltd., Osaka, Japan), and further separated into enantiomers on a Pirkle-type enantioselective column (Singularity CSP-001S, 1.5 mm ID × 250 mm) (designed by Kyushu University and KAGAMI). Fluorescence of NBD-amino acids was detected at 530 nm with excitation at 470 nm. D-and L-serine peak in a chromatogram were detected and standard curve was drawn by the peak height of those standards. The absolute amount of D- and L-serine were calculated by standard curve method.</p>
</sec>
<sec id="s4g">
<title>Quantification of formate in the culture media</title>
<p>Formate concentration in the culture media was measured using Enzychrom Formate assay kit (BioAssay Systems) according to the manufacturer’s protocol.</p>
</sec>
<sec id="s4h">
<title>SHMT2 activity assays</title>
<p>The SHMT2 gene was cloned from cDNA of HeLa cells using primers 5’- GCCCATATGGCCATTCGGGCTCAGCAC-3’ (forward) and 5’- GCCCTCGAGATGCTCATCAAAACCAGGCA-3’ (reverse) and subcloned into the pET41a vector (Novagen, WI, USA) at restriction enzyme sites of NdeI and XhoI. C-terminally hexahistidine (His<sub>6</sub>)-tagged human SHMT2 was purified as follows. <italic>E. coli</italic> BL21 (DE3) pLysS-competent cells were transformed with pET41-SHMT2, cultured at 37 °C in Luria-Bertani medium containing 20 µg/mL kanamycin, and grown until the OD600 reached 0.6-0.7. Isopropyl β-D-thiogalactopyranoside was added to a final concentration of 0.5 mM, and culturing was continued for an additional 24 h at 20°C. Harvested cells were resuspended in 20 mM sodium phosphate buffer (pH7.4) containing 500 mM NaCl and protease inhibitors (Nacalai Tesque, Kyoto, Japan), and sonicated using a Sonifier 250 instrument (Branson, CT, USA). Lysed cells were centrifuged at 20,000 × g for 10 min at 4 °C, and imidazole was added to the supernatant to a final concentration of 100 mM. The supernatant was applied to a His SpinTrap column (Cytiva, Tokyo, Japan). The column was washed with 20 mM sodium phosphate buffer (pH7.4) containing 500 mM NaCl and 100 mM imidazole. and recombinant protein was eluted with 20 mM sodium phosphate buffer (pH7.4) containing 500 mM NaCl and 500 mM imidazole. Protein fractions were buffer-exchanged into 50 mM Tris-HCl (pH8.0) containing 100 mM NaCl and 10% glycerol using an Amicon Ultra-0.5 centrifugal filter 10K device (Merck Millipore, Darmstadt, Germany).</p>
<p>SHMT2 activity was determined by measuring the production of glycine. The reaction mixture (150 µL) contained 50 mM HEPES-NaOH (pH8.0), 0.2 mM L-serine, 50 μM PLP, 50 μM THF, 1 mM dithiothreitol, and recombinant SHMT2 (2 µg). D-serine was added at concentrations varying from 0.1 to 0.4 mM. The reaction mixture was incubated at 37 °C for 10 min, and then 600 µL of MeOH were added to terminate the reaction. Glycine was derivatized with ortho-phthaldialdehyde (OPA) and <italic>N</italic>-tert-butyloxycarbonyl-L-cysteine (Boc-L-Cys), and an aliquot (10 µL) was injected into an LC-4000 Series HPLC system (Jasco Corp., Tokyo, Japan) equipped with a Mightysil RP-18GP column (150 × 4.6 mm i.d.; Kanto Chemical Co., Tokyo, Japan). A gradient of solvent A (50 mM sodium acetate buffer, pH 6.0) and solvent B (acetonitrile) was applied at a flow rate of 1 mL/min. A linear gradient was applied for 35 min from 10% to 21% solvent B for glycine analysis. Excitation and emission wavelengths for fluorescence detection were 344 nm and 443 nm, respectively.</p>
</sec>
<sec id="s4i">
<title>L-serine transport assay in semi-permeabilized cells</title>
<p>Neuro2A cells were seeded on poly-D-lysine coated 24-well-plate, cultured for 3 days, and subjected to the transport assay. Transport of L-[<sup>3</sup>H]serine was examined in semi-permeabilized cells. For plasma membrane permeabilization, cells were treated with saponin, an agent that permeabilizes the plasma membrane but leaves membranous organelles intact(<xref ref-type="bibr" rid="c31">Klepinin et al., 2016</xref>; <xref ref-type="bibr" rid="c34">Kuznetsov et al., 2008</xref>). The optimized saponin concentration and treatment time were verified by optical microscopy. Transport assays were performed as described previously(<xref ref-type="bibr" rid="c37">Lee et al., 2022</xref>; <xref ref-type="bibr" rid="c66">Wiriyasermkul et al., 2012</xref>) with some modifications. After washing the cells with 37°C pre-warmed Dulbecco’s Phosphate Buffered Saline (DPBS) with 1 mM MgCl<sub>2</sub> and 0.25 mM CaCl<sub>2</sub>, they were incubated for 6 min in the same buffer containing 40 μg/mL saponin (Fujifilm) for plasma membrane permeabilization. Transport of 10 μM L- [<sup>3</sup>H]serine (100 Ci/mol; Moravek Biochemicals, Brea, CA, USA) with or without D-serine (at indicated concentrations) was measured for 10 min in the same buffer including saponin. After terminating the reaction and cell lysis, an aliquot of the lysate was used to measure protein concentration by BCA protein assay (Takara Bio). The lysate was mixed with OptiPhase HiSafe 3 (PerkinElmer), and radioisotope activity was monitored by LSC-8000 β-scintillation (Hitachi, Tokyo, Japan). Data shown in the figures were those subtracted from uptake values at 0 min. Kinetics of inhibition was fitted to the Nonlinear Regression: dose-response – inhibition model of GraphPad Prism 8.4.</p>
</sec>
<sec id="s4j">
<title>RNA-sequence and analysis</title>
<p>Neuro2a cells were cultured in D-MEM with 10% FBS. The medium was changed to D-MEM(−SG) including 10% dialyzed FBS with or without 5 mM D-serine. Cells were harvested in Trizol after 18 h of incubation at 37 °C in a CO<sub>2</sub> incubator. RNA was extracted from cells according to the manufacture’s protocol. mRNA libraries of each sample were prepared using a TruSeq Stranded mRNA library Kit (Illumina, San Diego, CA) according to the manufacturer’s protocol and paired end sequences were read by NovaSeq (Illumina). Adapter sequences were trimmed from raw sequences with Trim Galore (<ext-link ext-link-type="uri" xlink:href="https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/">https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/</ext-link>) and trimmed sequences were mapped to the mouse genome (GRCm38/mm10) using HISAT2 (<ext-link ext-link-type="uri" xlink:href="https://daehwankimlab.github.io/hisat2/">https://daehwankimlab.github.io/hisat2/</ext-link>). Aligned sequences were counted using FeatureCounts (<ext-link ext-link-type="uri" xlink:href="https://subread.sourceforge.net/">https://subread.sourceforge.net/</ext-link>). Differentially expressed genes were identified by DESeq2 (<ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/release/bioc/html/DESeq2.html">https://bioconductor.org/packages/release/bioc/html/DESeq2.html</ext-link>). Gene Set Enrichment analysis was performed to find enriched biological pathways using ClusterProfiler (<ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/release/bioc/html/clusterProfiler.html">https://bioconductor.org/packages/release/bioc/html/clusterProfiler.html</ext-link>) with the following settings: pAdjustMethod = fd, pvalueCutoff = 0.05, minGSSize = 10, maxGSSize = 400.</p>
</sec>
<sec id="s4k">
<title>Glioma stem cell culture</title>
<p>hG008 and hG020 cells, established from human glioblastoma specimens(<xref ref-type="bibr" rid="c15">Fukaya et al., 2016</xref>), were cultured in Ultra-Low attachment cell culture flasks (Corning, Kennebunk, ME, USA) in a medium, in which ingredients were manually mixed in MEM to make DMEM/Ham’s F-12 with HEPES without serine and glycine (D/H-SG). The D/H-SG medium was supplemented with 2% B-27 (ThermoFisher), 20 ng/mL recombinant human fibroblast growth factor-basic (PeproTech, Rocky Hill, NJ, USA), 20 ng/mL recombinant human epidermal growth factor (PeproTech), 1000 units/mL recombinant human leukemia inhibitory factor (Nacalai Tesque, Kyoto, Japan), and 1 unit/mL heparin. Sphere formation of hG008 cells (1×10<sup>4</sup> cells/well in 96-well plates with ultra-low attachment surface, Corning) was observed using EVOS M5000 (ThemoFisher) and the maximum diameter of spheres in each well was measured after 7 days of culture.</p>
</sec>
<sec id="s4l">
<title>Ex vivo cancer growth assay</title>
<p>U87 and hG008 cells were transduced with the lentiviral vector CSII-EF-ffLuc, and single-cell suspensions were cultured in 96-well plates. Xenografts were implanted in the brain of female BALB/c nude mice as described previously<sup>25</sup>. Briefly, mice were implanted with Venus fluorescence-labeled U87 (5×10<sup>5</sup> cells/2 μL in PBS) or hG008 (1×10<sup>5</sup> cells/2 μL in PBS) under anesthesia on a stereotaxic apparatus (Narishige Scientific Instrument Lab, Tokyo, Japan). Mice were sacrificed after 6 days (U87) or 35 days (hG008) of implantation. Mouse brains were dissected, cut into a 200-μm slices, and cultured on the Millicell cell culture inserts (Millipore-Sigma, Burlington, MA) placed on a 35 mm glass-bottom dish filled with D/H-SG medium with or without 100 mM D-serine. Fluorescence images were taken with a FV3000 (Olympus, Tokyo, Japan) on days 0 and 7 and analyzed with Image J software (<ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij/index.html">https://imagej.nih.gov/ij/index.html</ext-link>).</p>
</sec>
<sec id="s4m">
<title>Statistics</title>
<p>No statistical methods were used to predetermine sample size. Blinding was not performed. No randomization was used. Prism 10 (GraphPad Software) was used for data plotting and statistical analyses. Statistical significance was determined with unpaired t-tests to compare two groups, or one-way analysis of variance (ANOVA) for multiple comparisons when data were normally distributed and had equal variance. ANOVA was followed by Dunnett’s post-hoc test (comparison to control) or Tukey’s post-hoc test (comparisons among samples).</p>
</sec>
</sec>

</body>
<back>
<sec id="s5" sec-type="data-availability">
<title>Data availability</title>
<p>RNA-seq data are available at Gene Expression Omnibus (GEO) with accession number GSE268106.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>We thank Kenji Hamase and Masashi Mita for technical support on chiral amino acid analysis and Steven D Aird for editing the manuscript. This study was supported by the Grants-in-Aid for Scientific Research (KAKENHI) 15K19497 (MS), 17J10213 (MS), 22K19408 (JS), Keio Gijuku Fukuzawa</p>
<p>Memorial Fund for the Advancement of Education and Research (JS), and Keio Program for the Promotion of Next Generation Research Projects Type A (JS).</p>
</ack>
<sec id="additional-files" sec-type="supplementary-material">
<title>Additional files</title>
<supplementary-material id="video1">
<label>Supplementary video 1</label>
<media xlink:href="supplements/610855_file02.mp4"/>
</supplementary-material>
<supplementary-material id="video2">
<label>Supplementary video 2</label>
<media xlink:href="supplements/610855_file03.mp4"/>
</supplementary-material>
<supplementary-material id="supp1">
<label>supplementary materials</label>
<media xlink:href="supplements/610855_file04.docx"/>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Acuna-Hidalgo</surname> <given-names>R</given-names></string-name>, <string-name><surname>Schanze</surname> <given-names>D</given-names></string-name>, <string-name><surname>Kariminejad</surname> <given-names>A</given-names></string-name>, <string-name><surname>Nordgren</surname> <given-names>A</given-names></string-name>, <string-name><surname>Kariminejad</surname> <given-names>MH</given-names></string-name>, <string-name><surname>Conner</surname> <given-names>P</given-names></string-name>, <string-name><surname>Grigelioniene</surname> <given-names>G</given-names></string-name>, <string-name><surname>Nilsson</surname> <given-names>D</given-names></string-name>, <string-name><surname>Nordenskjöld</surname> <given-names>M</given-names></string-name>, <string-name><surname>Wedell</surname> <given-names>A</given-names></string-name>, <string-name><surname>Freyer</surname> <given-names>C</given-names></string-name>, <string-name><surname>Wredenberg</surname> <given-names>A</given-names></string-name>, <string-name><surname>Wieczorek</surname> <given-names>D</given-names></string-name>, <string-name><surname>Gillessen-Kaesbach</surname> <given-names>G</given-names></string-name>, <string-name><surname>Kayserili</surname> <given-names>H</given-names></string-name>, <string-name><surname>Elcioglu</surname> <given-names>N</given-names></string-name>, <string-name><surname>Ghaderi-Sohi</surname> <given-names>S</given-names></string-name>, <string-name><surname>Goodarzi</surname> <given-names>P</given-names></string-name>, <string-name><surname>Setayesh</surname> <given-names>H</given-names></string-name>, <string-name><surname>van de Vorst</surname> <given-names>M</given-names></string-name>, <string-name><surname>Steehouwer</surname> <given-names>M</given-names></string-name>, <string-name><surname>Pfundt</surname> <given-names>R</given-names></string-name>, <string-name><surname>Krabichler</surname> <given-names>B</given-names></string-name>, <string-name><surname>Curry</surname> <given-names>C</given-names></string-name>, <string-name><surname>MacKenzie</surname> <given-names>MG</given-names></string-name>, <string-name><surname>Boycott</surname> <given-names>KM</given-names></string-name>, <string-name><surname>Gilissen</surname> <given-names>C</given-names></string-name>, <string-name><surname>Janecke</surname> <given-names>AR</given-names></string-name>, <string-name><surname>Hoischen</surname> <given-names>A</given-names></string-name>, <string-name><surname>Zenker</surname> <given-names>M.</given-names></string-name></person-group> <year>2014</year>. <article-title>Neu-Laxova Syndrome Is a Heterogeneous Metabolic Disorder Caused by Defects in Enzymes of the L-Serine Biosynthesis Pathway</article-title>. <source>Am J Hum Genet</source> <volume>95</volume>:<fpage>285</fpage>–<lpage>293</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ajhg.2014.07.012</pub-id></mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Archibald</surname> <given-names>JM</given-names></string-name></person-group>. <year>2015</year>. <article-title>Endosymbiosis and Eukaryotic Cell Evolution</article-title>. <source>Curr Biol</source> <volume>25</volume>:<fpage>R911</fpage>–<lpage>R921</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cub.2015.07.055</pub-id></mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Balu</surname> <given-names>DT</given-names></string-name>, <string-name><surname>Basu</surname> <given-names>AC</given-names></string-name>, <string-name><surname>Corradi</surname> <given-names>JP</given-names></string-name>, <string-name><surname>Cacace</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Coyle</surname> <given-names>JT</given-names></string-name></person-group>. <year>2012</year>. <article-title>The NMDA receptor co-agonists, d-serine and glycine, regulate neuronal dendritic architecture in the somatosensory cortex</article-title>. <source>Neurobiol Dis</source> <volume>45</volume>:<fpage>671</fpage>–<lpage>682</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.nbd.2011.10.006</pub-id></mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Balu</surname> <given-names>DT</given-names></string-name>, <string-name><surname>Takagi</surname> <given-names>S</given-names></string-name>, <string-name><surname>Puhl</surname> <given-names>MD</given-names></string-name>, <string-name><surname>Benneyworth</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Coyle</surname> <given-names>JT</given-names></string-name></person-group>. <year>2014</year>. <article-title>d-Serine and Serine Racemase are Localized to Neurons in the Adult Mouse and Human Forebrain</article-title>. <source>Cell Mol Neurobiol</source> <volume>34</volume>:<fpage>419</fpage>–<lpage>435</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10571-014-0027-z</pub-id></mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Basu</surname> <given-names>AC</given-names></string-name>, <string-name><surname>Tsai</surname> <given-names>GE</given-names></string-name>, <string-name><surname>Ma</surname> <given-names>C-L</given-names></string-name>, <string-name><surname>Ehmsen</surname> <given-names>JT</given-names></string-name>, <string-name><surname>Mustafa</surname> <given-names>AK</given-names></string-name>, <string-name><surname>Han</surname> <given-names>L</given-names></string-name>, <string-name><surname>Jiang</surname> <given-names>ZI</given-names></string-name>, <string-name><surname>Benneyworth</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Froimowitz</surname> <given-names>MP</given-names></string-name>, <string-name><surname>Lange</surname> <given-names>N</given-names></string-name>, <string-name><surname>Snyder</surname> <given-names>SH</given-names></string-name>, <string-name><surname>Bergeron</surname> <given-names>R</given-names></string-name>, <string-name><surname>Coyle</surname> <given-names>JT</given-names></string-name></person-group>. <year>2009</year>. <article-title>Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior</article-title>. <source>Mol Psychiatry</source> <volume>14</volume>:<fpage>719</fpage>–<lpage>727</lpage>. doi:<pub-id pub-id-type="doi">10.1038/mp.2008.130</pub-id></mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Beaudin</surname> <given-names>AE</given-names></string-name>, <string-name><surname>Stover</surname> <given-names>PJ</given-names></string-name></person-group>. <year>2009</year>. <article-title>Insights into metabolic mechanisms underlying folate-responsive neural tube defects: A minireview</article-title>. <source>Birth Defects Res Part A: Clin Mol Teratol</source> <volume>85</volume>:<fpage>274</fpage>–<lpage>284</lpage>. doi:<pub-id pub-id-type="doi">10.1002/bdra.20553</pub-id></mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bella</surname> <given-names>DJD</given-names></string-name>, <string-name><surname>Habibi</surname> <given-names>E</given-names></string-name>, <string-name><surname>Stickels</surname> <given-names>RR</given-names></string-name>, <string-name><surname>Scalia</surname> <given-names>G</given-names></string-name>, <string-name><surname>Brown</surname> <given-names>J</given-names></string-name>, <string-name><surname>Yadollahpour</surname> <given-names>P</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>SM</given-names></string-name>, <string-name><surname>Abbate</surname> <given-names>C</given-names></string-name>, <string-name><surname>Biancalani</surname> <given-names>T</given-names></string-name>, <string-name><surname>Macosko</surname> <given-names>EZ</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>F</given-names></string-name>, <string-name><surname>Regev</surname> <given-names>A</given-names></string-name>, <string-name><surname>Arlotta</surname> <given-names>P.</given-names></string-name></person-group> <year>2021</year>. <article-title>Molecular logic of cellular diversification in the mouse cerebral cortex</article-title>. <source>Nature</source> <volume>595</volume>:<fpage>554</fpage>–<lpage>559</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41586-021-03670-5</pub-id></mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bent</surname> <given-names>MJ van den</given-names></string-name>, <string-name><surname>Geurts</surname> <given-names>M</given-names></string-name>, <string-name><surname>French</surname> <given-names>PJ</given-names></string-name>, <string-name><surname>Smits</surname> <given-names>M</given-names></string-name>, <string-name><surname>Capper</surname> <given-names>D</given-names></string-name>, <string-name><surname>Bromberg</surname> <given-names>JEC</given-names></string-name>, <string-name><surname>Chang</surname> <given-names>SM</given-names></string-name></person-group>. <year>2023</year>. <article-title>Primary brain tumours in adults</article-title>. <source>Lancet</source> <volume>402</volume>:<fpage>1564</fpage>–<lpage>1579</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0140-6736(23)01054-1</pub-id></mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Burke</surname> <given-names>EE</given-names></string-name>, <string-name><surname>Chenoweth</surname> <given-names>JG</given-names></string-name>, <string-name><surname>Shin</surname> <given-names>JH</given-names></string-name>, <string-name><surname>Collado-Torres</surname> <given-names>L</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>S-K</given-names></string-name>, <string-name><surname>Micali</surname> <given-names>N</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Colantuoni</surname> <given-names>C</given-names></string-name>, <string-name><surname>Straub</surname> <given-names>RE</given-names></string-name>, <string-name><surname>Hoeppner</surname> <given-names>DJ</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>H-Y</given-names></string-name>, <string-name><surname>Sellers</surname> <given-names>A</given-names></string-name>, <string-name><surname>Shibbani</surname> <given-names>K</given-names></string-name>, <string-name><surname>Hamersky</surname> <given-names>GR</given-names></string-name>, <string-name><surname>Bustamante</surname> <given-names>MD</given-names></string-name>, <string-name><surname>Phan</surname> <given-names>BN</given-names></string-name>, <string-name><surname>Ulrich</surname> <given-names>WS</given-names></string-name>, <string-name><surname>Valencia</surname> <given-names>C</given-names></string-name>, <string-name><surname>Jaishankar</surname> <given-names>A</given-names></string-name>, <string-name><surname>Price</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Rajpurohit</surname> <given-names>A</given-names></string-name>, <string-name><surname>Semick</surname> <given-names>SA</given-names></string-name>, <string-name><surname>Bürli</surname> <given-names>RW</given-names></string-name>, <string-name><surname>Barrow</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Hiler</surname> <given-names>DJ</given-names></string-name>, <string-name><surname>Page</surname> <given-names>SC</given-names></string-name>, <string-name><surname>Martinowich</surname> <given-names>K</given-names></string-name>, <string-name><surname>Hyde</surname> <given-names>TM</given-names></string-name>, <string-name><surname>Kleinman</surname> <given-names>JE</given-names></string-name>, <string-name><surname>Berman</surname> <given-names>KF</given-names></string-name>, <string-name><surname>Apud</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Cross</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Brandon</surname> <given-names>NJ</given-names></string-name>, <string-name><surname>Weinberger</surname> <given-names>DR</given-names></string-name>, <string-name><surname>Maher</surname> <given-names>BJ</given-names></string-name>, <string-name><surname>McKay</surname> <given-names>RDG</given-names></string-name>, <string-name><surname>Jaffe</surname> <given-names>AE</given-names></string-name></person-group>. <year>2020</year>. <article-title>Dissecting transcriptomic signatures of neuronal differentiation and maturation using iPSCs</article-title>. <source>Nat Commun</source> <volume>11</volume>:<fpage>462</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41467-019-14266-z</pub-id></mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chatterton</surname> <given-names>JE</given-names></string-name>, <string-name><surname>Awobuluyi</surname> <given-names>M</given-names></string-name>, <string-name><surname>Premkumar</surname> <given-names>LS</given-names></string-name>, <string-name><surname>Takahashi</surname> <given-names>H</given-names></string-name>, <string-name><surname>Talantova</surname> <given-names>M</given-names></string-name>, <string-name><surname>Shin</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Cui</surname> <given-names>J</given-names></string-name>, <string-name><surname>Tu</surname> <given-names>S</given-names></string-name>, <string-name><surname>Sevarino</surname> <given-names>KA</given-names></string-name>, <string-name><surname>Nakanishi</surname> <given-names>N</given-names></string-name>, <string-name><surname>Tong</surname> <given-names>G</given-names></string-name>, <string-name><surname>Lipton</surname> <given-names>SA</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>D.</given-names></string-name></person-group> <year>2002</year>. <article-title>Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits</article-title>. <source>Nature</source> <volume>415</volume>:<fpage>793</fpage>–<lpage>798</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature715</pub-id></mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cosloy</surname> <given-names>SD</given-names></string-name>, <string-name><surname>McFall</surname> <given-names>E.</given-names></string-name></person-group> <year>1973</year>. <article-title>Metabolism of d-Serine in Escherichia coli K-12: Mechanism of Growth Inhibition</article-title>. <source>J Bacteriol</source> <volume>114</volume>:<fpage>685</fpage>–<lpage>694</lpage>. doi:<pub-id pub-id-type="doi">10.1128/jb.114.2.685-694.1973</pub-id></mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Delgado-López</surname> <given-names>PD</given-names></string-name>, <string-name><surname>Corrales-García</surname> <given-names>EM</given-names></string-name></person-group>. <year>2016</year>. <article-title>Survival in glioblastoma: a review on the impact of treatment modalities</article-title>. <source>Clin Transl Oncol</source> <volume>18</volume>:<fpage>1062</fpage>–<lpage>1071</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s12094-016-1497-x</pub-id></mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ducker</surname> <given-names>GS</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>L</given-names></string-name>, <string-name><surname>Morscher</surname> <given-names>RJ</given-names></string-name>, <string-name><surname>Ghergurovich</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Esposito</surname> <given-names>M</given-names></string-name>, <string-name><surname>Teng</surname> <given-names>X</given-names></string-name>, <string-name><surname>Kang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Rabinowitz</surname> <given-names>JD</given-names></string-name></person-group>. <year>2016</year>. <article-title>Reversal of Cytosolic One-Carbon Flux Compensates for Loss of the Mitochondrial Folate Pathway</article-title>. <source>Cell Metab</source> <volume>23</volume>:<fpage>1140</fpage>–<lpage>1153</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cmet.2016.04.016</pub-id></mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ducker</surname> <given-names>GS</given-names></string-name>, <string-name><surname>Rabinowitz</surname> <given-names>JD</given-names></string-name></person-group>. <year>2017</year>. <article-title>One-Carbon Metabolism in Health and Disease</article-title>. <source>Cell Metab</source> <volume>25</volume>:<fpage>27</fpage>–<lpage>42</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cmet.2016.08.009</pub-id></mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fukaya</surname> <given-names>R</given-names></string-name>, <string-name><surname>Ohta</surname> <given-names>S</given-names></string-name>, <string-name><surname>Yaguchi</surname> <given-names>T</given-names></string-name>, <string-name><surname>Matsuzaki</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Sugihara</surname> <given-names>E</given-names></string-name>, <string-name><surname>Okano</surname> <given-names>H</given-names></string-name>, <string-name><surname>Saya</surname> <given-names>H</given-names></string-name>, <string-name><surname>Kawakami</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Kawase</surname> <given-names>T</given-names></string-name>, <string-name><surname>Yoshida</surname> <given-names>K</given-names></string-name>, <string-name><surname>Toda</surname> <given-names>M.</given-names></string-name></person-group> <year>2016</year>. <article-title>MIF Maintains the Tumorigenic Capacity of Brain Tumor–Initiating Cells by Directly Inhibiting p53</article-title>. <source>Cancer Res</source> <volume>76</volume>:<fpage>2813</fpage>–<lpage>2823</lpage>. doi:<pub-id pub-id-type="doi">10.1158/0008-5472.can-15-1011</pub-id></mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Furukawa</surname> <given-names>H</given-names></string-name>, <string-name><surname>Gouaux</surname> <given-names>E.</given-names></string-name></person-group> <year>2003</year>. <article-title>Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core</article-title>. <source>The EMBO Journal</source>. doi:<pub-id pub-id-type="doi">10.1093/emboj/cdg303</pub-id></mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fuse</surname> <given-names>S</given-names></string-name>, <string-name><surname>Sugimoto</surname> <given-names>M</given-names></string-name>, <string-name><surname>Kurosawa</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Kuroiwa</surname> <given-names>M</given-names></string-name>, <string-name><surname>Aita</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Tomita</surname> <given-names>A</given-names></string-name>, <string-name><surname>Yamaguchi</surname> <given-names>E</given-names></string-name>, <string-name><surname>Tanaka</surname> <given-names>R</given-names></string-name>, <string-name><surname>Endo</surname> <given-names>T</given-names></string-name>, <string-name><surname>Kime</surname> <given-names>R</given-names></string-name>, <string-name><surname>Hamaoka</surname> <given-names>T.</given-names></string-name></person-group> <year>2020</year>. <article-title>Relationships between plasma lipidomic profiles and brown adipose tissue density in humans</article-title>. <source>Int J Obes</source> <volume>44</volume>:<fpage>1387</fpage>–<lpage>1396</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41366-020-0558-y</pub-id></mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Geeraerts</surname> <given-names>SL</given-names></string-name>, <string-name><surname>Heylen</surname> <given-names>E</given-names></string-name>, <string-name><surname>Keersmaecker</surname> <given-names>KD</given-names></string-name>, <string-name><surname>Kampen</surname> <given-names>KR</given-names></string-name></person-group>. <year>2021</year>. <article-title>The ins and outs of serine and glycine metabolism in cancer</article-title>. <source>Nat Metab</source> <volume>3</volume>:<fpage>131</fpage>–<lpage>141</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s42255-020-00329-9</pub-id></mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gimple</surname> <given-names>RC</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>K</given-names></string-name>, <string-name><surname>Halbert</surname> <given-names>ME</given-names></string-name>, <string-name><surname>Agnihotri</surname> <given-names>S</given-names></string-name>, <string-name><surname>Rich</surname> <given-names>JN</given-names></string-name></person-group>. <year>2022</year>. <article-title>Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity</article-title>. <source>Nat Rev Cancer</source> <volume>22</volume>:<fpage>497</fpage>–<lpage>514</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41568-022-00486-x</pub-id></mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gonda</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Ishii</surname> <given-names>C</given-names></string-name>, <string-name><surname>Mita</surname> <given-names>M</given-names></string-name>, <string-name><surname>Nishizaki</surname> <given-names>N</given-names></string-name>, <string-name><surname>Ohtomo</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Hamase</surname> <given-names>K</given-names></string-name>, <string-name><surname>Shimizu</surname> <given-names>T</given-names></string-name>, <string-name><surname>Sasabe</surname> <given-names>J.</given-names></string-name></person-group> <year>2022</year>. <article-title>Astrocytic d-amino acid oxidase degrades d-serine in the hindbrain</article-title>. <source>FEBS Lett</source> <volume>596</volume>:<fpage>2889</fpage>–<lpage>2897</lpage>. doi:<pub-id pub-id-type="doi">10.1002/1873-3468.14417</pub-id></mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gonda</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Matsuda</surname> <given-names>A</given-names></string-name>, <string-name><surname>Adachi</surname> <given-names>K</given-names></string-name>, <string-name><surname>Ishii</surname> <given-names>C</given-names></string-name>, <string-name><surname>Suzuki</surname> <given-names>M</given-names></string-name>, <string-name><surname>Osaki</surname> <given-names>A</given-names></string-name>, <string-name><surname>Mita</surname> <given-names>M</given-names></string-name>, <string-name><surname>Nishizaki</surname> <given-names>N</given-names></string-name>, <string-name><surname>Ohtomo</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Shimizu</surname> <given-names>T</given-names></string-name>, <string-name><surname>Yasui</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hamase</surname> <given-names>K</given-names></string-name>, <string-name><surname>Sasabe</surname> <given-names>J.</given-names></string-name></person-group> <year>2023</year>. <article-title>Mammals sustain amino acid homochirality against chiral conversion by symbiotic microbes</article-title>. <source>Proc Natl Acad Sci U S A</source>. doi:<pub-id pub-id-type="doi">10.1073/pnas.2300817120</pub-id></mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hashimoto</surname> <given-names>A</given-names></string-name>, <string-name><surname>Nishikawa</surname> <given-names>T</given-names></string-name>, <string-name><surname>Oka</surname> <given-names>T</given-names></string-name>, <string-name><surname>Takahashi</surname> <given-names>K.</given-names></string-name></person-group> <year>1993</year>. <article-title>Endogenous d-Serine in Rat Brain: N-Methyl-d-Aspartate Receptor-Related Distribution and Aging</article-title>. <source>J Neurochem</source> <volume>60</volume>:<fpage>783</fpage>–<lpage>786</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1471-4159.1993.tb03219.x</pub-id></mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hirabayashi</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Furuya</surname> <given-names>S.</given-names></string-name></person-group> <year>2008</year>. <article-title>Roles of l-serine and sphingolipid synthesis in brain development and neuronal survival</article-title>. <source>Prog Lipid Res</source> <volume>47</volume>:<fpage>188</fpage>–<lpage>203</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.plipres.2008.01.003</pub-id></mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Horn</surname> <given-names>MRV</given-names></string-name>, <string-name><surname>Strasser</surname> <given-names>A</given-names></string-name>, <string-name><surname>Miraucourt</surname> <given-names>LS</given-names></string-name>, <string-name><surname>Pollegioni</surname> <given-names>L</given-names></string-name>, <string-name><surname>Ruthazer</surname> <given-names>ES</given-names></string-name></person-group>. <year>2017</year>. <article-title>The Gliotransmitter d-Serine Promotes Synapse Maturation and Axonal Stabilization In Vivo</article-title>. <source>J Neurosci</source> <volume>37</volume>:<fpage>6277</fpage>–<lpage>6288</lpage>. doi:<pub-id pub-id-type="doi">10.1523/jneurosci.3158-16.2017</pub-id></mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hubbard</surname> <given-names>KS</given-names></string-name>, <string-name><surname>Gut</surname> <given-names>IM</given-names></string-name>, <string-name><surname>Lyman</surname> <given-names>ME</given-names></string-name>, <string-name><surname>McNutt</surname> <given-names>PM</given-names></string-name></person-group>. <year>2013</year>. <article-title>Longitudinal RNA sequencing of the deep transcriptome during neurogenesis of cortical glutamatergic neurons from murine ESCs</article-title>. <source>F1000research</source> <volume>2</volume>:<fpage>35</fpage>. doi:<pub-id pub-id-type="doi">10.12688/f1000research.2-35.v1</pub-id></mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Inoue</surname> <given-names>R</given-names></string-name>, <string-name><surname>Hashimoto</surname> <given-names>K</given-names></string-name>, <string-name><surname>Harai</surname> <given-names>T</given-names></string-name>, <string-name><surname>Mori</surname> <given-names>H.</given-names></string-name></person-group> <year>2008</year>. <article-title>NMDA- and β-Amyloid1–42-Induced Neurotoxicity Is Attenuated in Serine Racemase Knock-Out Mice</article-title>. <source>J Neurosci</source> <volume>28</volume>:<fpage>14486</fpage>–<lpage>14491</lpage>. doi:<pub-id pub-id-type="doi">10.1523/jneurosci.5034-08.2008</pub-id></mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ishii</surname> <given-names>C</given-names></string-name>, <string-name><surname>Akita</surname> <given-names>T</given-names></string-name>, <string-name><surname>Mita</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ide</surname> <given-names>T</given-names></string-name>, <string-name><surname>Hamase</surname> <given-names>K.</given-names></string-name></person-group> <year>2018</year>. <article-title>Development of an online two-dimensional high-performance liquid chromatographic system in combination with tandem mass spectrometric detection for enantiomeric analysis of free amino acids in human physiological fluid</article-title>. <source>J Chromatogr A</source> <volume>1570</volume>:<fpage>91</fpage>–<lpage>98</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chroma.2018.07.076</pub-id></mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jaeken</surname> <given-names>J</given-names></string-name>, <string-name><surname>Detheux</surname> <given-names>M</given-names></string-name>, <string-name><surname>Fryns</surname> <given-names>JP</given-names></string-name>, <string-name><surname>Collet</surname> <given-names>JF</given-names></string-name>, <string-name><surname>Alliet</surname> <given-names>P</given-names></string-name>, <string-name><surname>Schaftingen</surname> <given-names>EV</given-names></string-name></person-group>. <year>1997</year>. <article-title>Phosphoserine phosphatase deficiency in a patient with Williams syndrome</article-title>. <source>J Méd Genet</source> <volume>34</volume>:<fpage>594</fpage>. doi:<pub-id pub-id-type="doi">10.1136/jmg.34.7.594</pub-id></mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jain</surname> <given-names>M</given-names></string-name>, <string-name><surname>Nilsson</surname> <given-names>R</given-names></string-name>, <string-name><surname>Sharma</surname> <given-names>S</given-names></string-name>, <string-name><surname>Madhusudhan</surname> <given-names>N</given-names></string-name>, <string-name><surname>Kitami</surname> <given-names>T</given-names></string-name>, <string-name><surname>Souza</surname> <given-names>AL</given-names></string-name>, <string-name><surname>Kafri</surname> <given-names>R</given-names></string-name>, <string-name><surname>Kirschner</surname> <given-names>MW</given-names></string-name>, <string-name><surname>Clish</surname> <given-names>CB</given-names></string-name>, <string-name><surname>Mootha</surname> <given-names>VK</given-names></string-name></person-group>. <year>2012</year>. <article-title>Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation</article-title>. <source>Science</source> <volume>336</volume>:<fpage>1037</fpage>–<lpage>1040</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1218595</pub-id></mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kaltenbach</surname> <given-names>JP</given-names></string-name>, <string-name><surname>Ganote</surname> <given-names>CE</given-names></string-name>, <string-name><surname>Carone</surname> <given-names>FA</given-names></string-name></person-group>. <year>1979</year>. <article-title>Renal tubular necrosis induced by compounds structurally related to d-serine</article-title>. <source>Exp Mol Pathol</source> <volume>30</volume>:<fpage>209</fpage>–<lpage>214</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0014-4800(79)90054-6</pub-id></mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Klepinin</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ounpuu</surname> <given-names>L</given-names></string-name>, <string-name><surname>Guzun</surname> <given-names>R</given-names></string-name>, <string-name><surname>Chekulayev</surname> <given-names>V</given-names></string-name>, <string-name><surname>Timohhina</surname> <given-names>N</given-names></string-name>, <string-name><surname>Tepp</surname> <given-names>K</given-names></string-name>, <string-name><surname>Shevchuk</surname> <given-names>I</given-names></string-name>, <string-name><surname>Schlattner</surname> <given-names>U</given-names></string-name>, <string-name><surname>Kaambre</surname> <given-names>T.</given-names></string-name></person-group> <year>2016</year>. <article-title>Simple oxygraphic analysis for the presence of adenylate kinase 1 and 2 in normal and tumor cells</article-title>. <source>J Bioenerg Biomembr</source> <volume>48</volume>:<fpage>531</fpage>–<lpage>548</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10863-016-9687-3</pub-id></mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Koning</surname> <given-names>TJD</given-names></string-name>, <string-name><surname>Duran</surname> <given-names>M</given-names></string-name>, <string-name><surname>Maldergem</surname> <given-names>LV</given-names></string-name>, <string-name><surname>Pineda</surname> <given-names>M</given-names></string-name>, <string-name><surname>Dorland</surname> <given-names>L</given-names></string-name>, <string-name><surname>Gooskens</surname> <given-names>R</given-names></string-name>, <string-name><surname>POLL-T</surname> <given-names>JJ</given-names></string-name> and <collab>BT</collab></person-group>. <year>2002</year>. <article-title>Congenital microcephaly and seizures due to 3-phosphoglycerate dehydrogenase deficiency: Outcome of treatment with amino acids</article-title>. <source>J Inherit Metab Dis</source>.</mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kory</surname> <given-names>N</given-names></string-name>, <string-name><surname>Wyant</surname> <given-names>GA</given-names></string-name>, <string-name><surname>Prakash</surname> <given-names>G</given-names></string-name>, <string-name><given-names>Bos J uit</given-names> <surname>de</surname></string-name>, <string-name><surname>Bottanelli</surname> <given-names>F</given-names></string-name>, <string-name><surname>Pacold</surname> <given-names>ME</given-names></string-name>, <string-name><surname>Chan</surname> <given-names>SH</given-names></string-name>, <string-name><surname>Lewis</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>T</given-names></string-name>, <string-name><surname>Keys</surname> <given-names>HR</given-names></string-name>, <string-name><surname>Guo</surname> <given-names>YE</given-names></string-name>, <string-name><surname>Sabatini</surname> <given-names>DM</given-names></string-name></person-group>. <year>2018</year>. <article-title>SFXN1 is a mitochondrial serine transporter required for one-carbon metabolism</article-title>. <source>Science</source> <volume>362</volume>. doi:<pub-id pub-id-type="doi">10.1126/science.aat9528</pub-id></mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kuznetsov</surname> <given-names>AV</given-names></string-name>, <string-name><surname>Veksler</surname> <given-names>V</given-names></string-name>, <string-name><surname>Gellerich</surname> <given-names>FN</given-names></string-name>, <string-name><surname>Saks</surname> <given-names>V</given-names></string-name>, <string-name><surname>Margreiter</surname> <given-names>R</given-names></string-name>, <string-name><surname>Kunz</surname> <given-names>WS</given-names></string-name></person-group>. <year>2008</year>. <article-title>Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells</article-title>. <source>Nat Protoc</source> <volume>3</volume>:<fpage>965</fpage>–<lpage>976</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nprot.2008.61</pub-id></mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Labuschagne</surname> <given-names>CF</given-names></string-name>, <string-name><surname>van den Broek</surname> <given-names>NJF</given-names></string-name>, <string-name><surname>Mackay</surname> <given-names>GM</given-names></string-name>, <string-name><surname>Vousden</surname> <given-names>KH</given-names></string-name>, <string-name><surname>Maddocks</surname> <given-names>ODK</given-names></string-name></person-group>. <year>2014</year>. <article-title>Serine, but Not Glycine, Supports One-Carbon Metabolism and Proliferation of Cancer Cells</article-title>. <source>Cell Reports</source> <volume>7</volume>:<fpage>1248</fpage>–<lpage>1258</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.celrep.2014.04.045</pub-id></mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname> <given-names>GY</given-names></string-name>, <string-name><surname>Haverty</surname> <given-names>PM</given-names></string-name>, <string-name><surname>Li</surname> <given-names>L</given-names></string-name>, <string-name><surname>Kljavin</surname> <given-names>NM</given-names></string-name>, <string-name><surname>Bourgon</surname> <given-names>R</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>J</given-names></string-name>, <string-name><surname>Stern</surname> <given-names>H</given-names></string-name>, <string-name><surname>Modrusan</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Seshagiri</surname> <given-names>S</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Davis</surname> <given-names>D</given-names></string-name>, <string-name><surname>Stokoe</surname> <given-names>D</given-names></string-name>, <string-name><surname>Settleman</surname> <given-names>J</given-names></string-name>, <string-name><surname>Sauvage</surname> <given-names>FJ de</given-names></string-name>, <string-name><surname>Neve</surname> <given-names>RM</given-names></string-name></person-group>. <year>2014</year>. <article-title>Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes</article-title>. <source>Cancer Res</source> <volume>74</volume>:<fpage>3114</fpage>–<lpage>3126</lpage>. doi:<pub-id pub-id-type="doi">10.1158/0008-5472.can-13-2683</pub-id></mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Wiriyasermkul</surname> <given-names>P</given-names></string-name>, <string-name><surname>Kongpracha</surname> <given-names>P</given-names></string-name>, <string-name><surname>Moriyama</surname> <given-names>S</given-names></string-name>, <string-name><surname>Mills</surname> <given-names>DJ</given-names></string-name>, <string-name><surname>Kühlbrandt</surname> <given-names>W</given-names></string-name>, <string-name><surname>Nagamori</surname> <given-names>S.</given-names></string-name></person-group> <year>2022</year>. <article-title>Ca2+-mediated higher-order assembly of heterodimers in amino acid transport system b0,+ biogenesis and cystinuria</article-title>. <source>Nat Commun</source> <volume>13</volume>:<fpage>2708</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41467-022-30293-9</pub-id></mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lewis</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Parker</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Fiske</surname> <given-names>BP</given-names></string-name>, <string-name><surname>McCloskey</surname> <given-names>D</given-names></string-name>, <string-name><surname>Gui</surname> <given-names>DY</given-names></string-name>, <string-name><surname>Green</surname> <given-names>CR</given-names></string-name>, <string-name><surname>Vokes</surname> <given-names>NI</given-names></string-name>, <string-name><surname>Feist</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Vander Heiden</surname> <given-names>MG</given-names></string-name>, <string-name><surname>Metallo</surname> <given-names>CM</given-names></string-name></person-group>. <year>2014</year>. <article-title>Tracing Compartmentalized NADPH Metabolism in the Cytosol and Mitochondria of Mammalian Cells</article-title>. <source>Mol Cell</source> <volume>55</volume>:<fpage>253</fpage>–<lpage>263</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molcel.2014.05.008</pub-id></mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lynch</surname> <given-names>JW</given-names></string-name></person-group>. <year>2004</year>. <article-title>Molecular Structure and Function of the Glycine Receptor Chloride Channel</article-title>. <source>Physiol Rev</source> <volume>84</volume>:<fpage>1051</fpage>–<lpage>1095</lpage>. doi:<pub-id pub-id-type="doi">10.1152/physrev.00042.2003</pub-id></mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>MacFarlane</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>X</given-names></string-name>, <string-name><surname>Perry</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Flodby</surname> <given-names>P</given-names></string-name>, <string-name><surname>Allen</surname> <given-names>RH</given-names></string-name>, <string-name><surname>Stabler</surname> <given-names>SP</given-names></string-name>, <string-name><surname>Stover</surname> <given-names>PJ</given-names></string-name></person-group>. <year>2008</year>. <article-title>Cytoplasmic Serine Hydroxymethyltransferase Regulates the Metabolic Partitioning of Methylenetetrahydrofolate but Is Not Essential in Mice*</article-title>. <source>J Biol Chem</source> <volume>283</volume>:<fpage>25846</fpage>–<lpage>25853</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.m802671200</pub-id></mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Maekawa</surname> <given-names>M</given-names></string-name>, <string-name><surname>Okamura</surname> <given-names>T</given-names></string-name>, <string-name><surname>Kasai</surname> <given-names>N</given-names></string-name>, <string-name><surname>Hori</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Summer</surname> <given-names>KH</given-names></string-name>, <string-name><surname>Konno</surname> <given-names>R.</given-names></string-name></person-group> <year>2005</year>. <article-title>d-Amino-acid Oxidase Is Involved in d-Serine-Induced Nephrotoxicity</article-title>. <source>Chem Res Toxicol</source> <volume>18</volume>:<fpage>1678</fpage>–<lpage>1682</lpage>. doi:<pub-id pub-id-type="doi">10.1021/tx0500326</pub-id></mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McNamara</surname> <given-names>D</given-names></string-name>, <string-name><surname>Dingledine</surname> <given-names>R.</given-names></string-name></person-group> <year>1990</year>. <article-title>Dual effect of glycine on NMDA-induced neurotoxicity in rat cortical cultures</article-title>. <source>J Neurosci</source> <volume>10</volume>:<fpage>3970</fpage>–<lpage>3976</lpage>. doi:<pub-id pub-id-type="doi">10.1523/jneurosci.10-12-03970.1990</pub-id></mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Miya</surname> <given-names>K</given-names></string-name>, <string-name><surname>Inoue</surname> <given-names>R</given-names></string-name>, <string-name><surname>Takata</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Abe</surname> <given-names>M</given-names></string-name>, <string-name><surname>Natsume</surname> <given-names>R</given-names></string-name>, <string-name><surname>Sakimura</surname> <given-names>K</given-names></string-name>, <string-name><surname>Hongou</surname> <given-names>K</given-names></string-name>, <string-name><surname>Miyawaki</surname> <given-names>T</given-names></string-name>, <string-name><surname>Mori</surname> <given-names>H.</given-names></string-name></person-group> <year>2008</year>. <article-title>Serine racemase is predominantly localized in neurons in mouse brain</article-title>. <source>J Comp Neurol</source> <volume>510</volume>:<fpage>641</fpage>–<lpage>654</lpage>. doi:<pub-id pub-id-type="doi">10.1002/cne.21822</pub-id></mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Miyamoto</surname> <given-names>T</given-names></string-name>, <string-name><surname>Fushinobu</surname> <given-names>S</given-names></string-name>, <string-name><surname>Saitoh</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Sekine</surname> <given-names>M</given-names></string-name>, <string-name><surname>Katane</surname> <given-names>M</given-names></string-name>, <string-name><surname>Sakai Kato</surname> <given-names>K</given-names></string-name>, <string-name><surname>Homma</surname> <given-names>H.</given-names></string-name></person-group> <year>2024</year>. <article-title>Novel tetrahydrofolate-dependent d-serine dehydratase activity of serine hydroxymethyltransferases</article-title>. <source>Febs J</source> <volume>291</volume>:<fpage>308</fpage>–<lpage>322</lpage>. doi:<pub-id pub-id-type="doi">10.1111/febs.16953</pub-id></mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Miyoshi</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Hamase</surname> <given-names>K</given-names></string-name>, <string-name><surname>Tojo</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Mita</surname> <given-names>M</given-names></string-name>, <string-name><surname>Konno</surname> <given-names>R</given-names></string-name>, <string-name><surname>Zaitsu</surname> <given-names>K.</given-names></string-name></person-group> <year>2009</year>. <article-title>Determination of d-serine and d-alanine in the tissues and physiological fluids of mice with various d-amino-acid oxidase activities using two-dimensional high-performance liquid chromatography with fluorescence detection</article-title>. <source>J Chromatogr B</source> <volume>877</volume>:<fpage>2506</fpage>–<lpage>2512</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jchromb.2009.06.028</pub-id></mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mothet</surname> <given-names>J-P</given-names></string-name>, <string-name><surname>Parent</surname> <given-names>AT</given-names></string-name>, <string-name><surname>Wolosker</surname> <given-names>H</given-names></string-name>, <string-name><surname>Brady</surname> <given-names>RO</given-names></string-name>, <string-name><surname>Linden</surname> <given-names>DJ</given-names></string-name>, <string-name><surname>Ferris</surname> <given-names>CD</given-names></string-name>, <string-name><surname>Rogawski</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Snyder</surname> <given-names>SH</given-names></string-name></person-group>. <year>2000</year>. <article-title>d-Serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor</article-title>. <source>Proc Natl Acad Sci</source> <volume>97</volume>:<fpage>4926</fpage>–<lpage>4931</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.97.9.4926</pub-id></mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mustafa</surname> <given-names>AK</given-names></string-name>, <string-name><surname>Ahmad</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Zeynalov</surname> <given-names>E</given-names></string-name>, <string-name><surname>Gazi</surname> <given-names>SK</given-names></string-name>, <string-name><surname>Sikka</surname> <given-names>G</given-names></string-name>, <string-name><surname>Ehmsen</surname> <given-names>JT</given-names></string-name>, <string-name><surname>Barrow</surname> <given-names>RK</given-names></string-name>, <string-name><surname>Coyle</surname> <given-names>JT</given-names></string-name>, <string-name><surname>Snyder</surname> <given-names>SH</given-names></string-name>, <string-name><surname>Doré</surname> <given-names>S.</given-names></string-name></person-group> <year>2010</year>. <article-title>Serine Racemase Deletion Protects Against Cerebral Ischemia and Excitotoxicity</article-title>. <source>J Neurosci</source> <volume>30</volume>:<fpage>1413</fpage>–<lpage>1416</lpage>. doi:<pub-id pub-id-type="doi">10.1523/jneurosci.4297-09.2010</pub-id></mixed-citation></ref>
<ref id="c48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nagata</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Horiike</surname> <given-names>K</given-names></string-name>, <string-name><surname>Maeda</surname> <given-names>T.</given-names></string-name></person-group> <year>1994</year>. <article-title>Distribution of freed-serine in vertebrate brains</article-title>. <source>Brain Res</source> <volume>634</volume>:<fpage>291</fpage>–<lpage>295</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0006-8993(94)91932-1</pub-id></mixed-citation></ref>
<ref id="c49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nancy</surname> <given-names>KW</given-names></string-name>, <string-name><surname>Dingledine</surname> <given-names>R.</given-names></string-name></person-group> <year>1988</year>. <article-title>Requirement for Glycine in Activation of NMDA-Receptors Expressed in Xenopus Oocytes</article-title>. <source>science</source>.</mixed-citation></ref>
<ref id="c50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Newman</surname> <given-names>AC</given-names></string-name>, <string-name><surname>Maddocks</surname> <given-names>ODK</given-names></string-name></person-group>. <year>2017</year>. <article-title>One-carbon metabolism in cancer</article-title>. <source>Br J Cancer</source> <volume>116</volume>:<fpage>1499</fpage>–<lpage>1504</lpage>. doi:<pub-id pub-id-type="doi">10.1038/bjc.2017.118</pub-id></mixed-citation></ref>
<ref id="c51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nilsson</surname> <given-names>R</given-names></string-name>, <string-name><surname>Jain</surname> <given-names>M</given-names></string-name>, <string-name><surname>Madhusudhan</surname> <given-names>N</given-names></string-name>, <string-name><surname>Sheppard</surname> <given-names>NG</given-names></string-name>, <string-name><surname>Strittmatter</surname> <given-names>L</given-names></string-name>, <string-name><surname>Kampf</surname> <given-names>C</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>J</given-names></string-name>, <string-name><surname>Asplund</surname> <given-names>A</given-names></string-name>, <string-name><surname>Mootha</surname> <given-names>VK</given-names></string-name></person-group>. <year>2014</year>. <article-title>Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer</article-title>. <source>Nat Commun</source> <volume>5</volume>:<fpage>3128</fpage>. doi:<pub-id pub-id-type="doi">10.1038/ncomms4128</pub-id></mixed-citation></ref>
<ref id="c52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nomura</surname> <given-names>J</given-names></string-name>, <string-name><surname>Jaaro-Peled</surname> <given-names>H</given-names></string-name>, <string-name><surname>Lewis</surname> <given-names>E</given-names></string-name>, <string-name><surname>Nuñez-Abades</surname> <given-names>P</given-names></string-name>, <string-name><surname>Huppe-Gourgues</surname> <given-names>F</given-names></string-name>, <string-name><surname>Cash-Padgett</surname> <given-names>T</given-names></string-name>, <string-name><surname>Emiliani</surname> <given-names>F</given-names></string-name>, <string-name><surname>Kondo</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Furuya</surname> <given-names>A</given-names></string-name>, <string-name><surname>Landek-Salgado</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Ayhan</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Kamiya</surname> <given-names>A</given-names></string-name>, <string-name><surname>Takumi</surname> <given-names>T</given-names></string-name>, <string-name><surname>Huganir</surname> <given-names>R</given-names></string-name>, <string-name><surname>Pletnikov</surname> <given-names>M</given-names></string-name>, <string-name><surname>O’Donnell</surname> <given-names>P</given-names></string-name>, <string-name><surname>Sawa</surname> <given-names>A.</given-names></string-name></person-group> <year>2016</year>. <article-title>Role for neonatal D-serine signaling: prevention of physiological and behavioral deficits in adult Pick1 knockout mice</article-title>. <source>Mol Psychiatry</source> <volume>21</volume>:<fpage>386</fpage>–<lpage>393</lpage>. doi:<pub-id pub-id-type="doi">10.1038/mp.2015.61</pub-id></mixed-citation></ref>
<ref id="c53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Okada</surname> <given-names>A</given-names></string-name>, <string-name><surname>Nangaku</surname> <given-names>M</given-names></string-name>, <string-name><surname>Jao</surname> <given-names>T-M</given-names></string-name>, <string-name><surname>Maekawa</surname> <given-names>H</given-names></string-name>, <string-name><surname>Ishimono</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Kawakami</surname> <given-names>T</given-names></string-name>, <string-name><surname>Inagi</surname> <given-names>R.</given-names></string-name></person-group> <year>2017</year>. <article-title>D-serine, a novel uremic toxin, induces senescence in human renal tubular cells via GCN2 activation</article-title>. <source>Sci Rep</source> <volume>7</volume>:<fpage>11168</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-017-11049-8</pub-id></mixed-citation></ref>
<ref id="c54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pan</surname> <given-names>S</given-names></string-name>, <string-name><surname>Fan</surname> <given-names>M</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Li</surname> <given-names>X</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>H.</given-names></string-name></person-group> <year>2020</year>. <article-title>Serine, glycine and one-carbon metabolism in cancer (Review)</article-title>. <source>Int J Oncol</source> <volume>58</volume>:<fpage>158</fpage>–<lpage>170</lpage>. doi:<pub-id pub-id-type="doi">10.3892/ijo.2020.5158</pub-id></mixed-citation></ref>
<ref id="c55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pang</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Chong</surname> <given-names>J</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>G</given-names></string-name>, <string-name><surname>de Lima Morais</surname> <given-names>DA</given-names></string-name>, <string-name><surname>Chang</surname> <given-names>L</given-names></string-name>, <string-name><surname>Barrette</surname> <given-names>M</given-names></string-name>, <string-name><surname>Gauthier</surname> <given-names>C</given-names></string-name>, <string-name><surname>Jacques</surname> <given-names>P-É</given-names></string-name>, <string-name><surname>Li</surname> <given-names>S</given-names></string-name>, <string-name><surname>Xia</surname> <given-names>J.</given-names></string-name></person-group> <year>2021</year>. <article-title>MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights</article-title>. <source>Nucleic Acids Res</source> <volume>49</volume>:<fpage>gkab382.</fpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkab382</pub-id></mixed-citation></ref>
<ref id="c56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Patel</surname> <given-names>J</given-names></string-name>, <string-name><surname>Zinkand</surname> <given-names>WC</given-names></string-name>, <string-name><surname>Thompson</surname> <given-names>C</given-names></string-name>, <string-name><surname>Keith</surname> <given-names>R</given-names></string-name>, <string-name><surname>Salama</surname> <given-names>A.</given-names></string-name></person-group> <year>1990</year>. <article-title>Role of Glycine in the N-Methyl-d-Aspartate-Mediated Neuronal Cytotoxicity</article-title>. <source>J Neurochem</source> <volume>54</volume>:<fpage>849</fpage>–<lpage>854</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1471-4159.1990.tb02329.x</pub-id></mixed-citation></ref>
<ref id="c57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Reya</surname> <given-names>T</given-names></string-name>, <string-name><surname>Morrison</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Clarke</surname> <given-names>MF</given-names></string-name>, <string-name><surname>Weissman</surname> <given-names>IL</given-names></string-name></person-group>. <year>2001</year>. <article-title>Stem cells, cancer, and cancer stem cells</article-title>. <source>Nature</source> <volume>414</volume>:<fpage>105</fpage>–<lpage>111</lpage>. doi:<pub-id pub-id-type="doi">10.1038/35102167</pub-id></mixed-citation></ref>
<ref id="c58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sasabe</surname> <given-names>J</given-names></string-name>, <string-name><surname>Chiba</surname> <given-names>T</given-names></string-name>, <string-name><surname>Yamada</surname> <given-names>M</given-names></string-name>, <string-name><surname>Okamoto</surname> <given-names>K</given-names></string-name>, <string-name><surname>Nishimoto</surname> <given-names>I</given-names></string-name>, <string-name><surname>Matsuoka</surname> <given-names>M</given-names></string-name>, <string-name><surname>Aiso</surname> <given-names>S.</given-names></string-name></person-group> <year>2007</year>. <article-title>D-Serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis</article-title>. <source>EMBO J</source> <volume>26</volume>:<fpage>4149</fpage>–<lpage>4159</lpage>. doi:<pub-id pub-id-type="doi">10.1038/sj.emboj.7601840</pub-id></mixed-citation></ref>
<ref id="c59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shleper</surname> <given-names>M</given-names></string-name>, <string-name><surname>Kartvelishvily</surname> <given-names>E</given-names></string-name>, <string-name><surname>Wolosker</surname> <given-names>H.</given-names></string-name></person-group> <year>2005</year>. <article-title>D-Serine Is the Dominant Endogenous Coagonist for NMDA Receptor Neurotoxicity in Organotypic Hippocampal Slices</article-title>. <source>J Neurosci</source> <volume>25</volume>:<fpage>9413</fpage>–<lpage>9417</lpage>. doi:<pub-id pub-id-type="doi">10.1523/jneurosci.3190-05.2005</pub-id></mixed-citation></ref>
<ref id="c60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sultan</surname> <given-names>S</given-names></string-name>, <string-name><surname>Li</surname> <given-names>L</given-names></string-name>, <string-name><surname>Moss</surname> <given-names>J</given-names></string-name>, <string-name><surname>Petrelli</surname> <given-names>F</given-names></string-name>, <string-name><surname>Cassé</surname> <given-names>F</given-names></string-name>, <string-name><surname>Gebara</surname> <given-names>E</given-names></string-name>, <string-name><surname>Lopatar</surname> <given-names>J</given-names></string-name>, <string-name><surname>Pfrieger</surname> <given-names>FW</given-names></string-name>, <string-name><surname>Bezzi</surname> <given-names>P</given-names></string-name>, <string-name><surname>Bischofberger</surname> <given-names>J</given-names></string-name>, <string-name><surname>Toni</surname> <given-names>N.</given-names></string-name></person-group> <year>2015</year>. <article-title>Synaptic Integration of Adult-Born Hippocampal Neurons Is Locally Controlled by Astrocytes</article-title>. <source>Neuron</source> <volume>88</volume>:<fpage>957</fpage>–<lpage>972</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuron.2015.10.037</pub-id></mixed-citation></ref>
<ref id="c61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tajan</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hennequart</surname> <given-names>M</given-names></string-name>, <string-name><surname>Cheung</surname> <given-names>EC</given-names></string-name>, <string-name><surname>Zani</surname> <given-names>F</given-names></string-name>, <string-name><surname>Hock</surname> <given-names>AK</given-names></string-name>, <string-name><surname>Legrave</surname> <given-names>N</given-names></string-name>, <string-name><surname>Maddocks</surname> <given-names>ODK</given-names></string-name>, <string-name><surname>Ridgway</surname> <given-names>RA</given-names></string-name>, <string-name><surname>Athineos</surname> <given-names>D</given-names></string-name>, <string-name><surname>Suárez-Bonnet</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ludwig</surname> <given-names>RL</given-names></string-name>, <string-name><surname>Novellasdemunt</surname> <given-names>L</given-names></string-name>, <string-name><surname>Angelis</surname> <given-names>N</given-names></string-name>, <string-name><surname>Li</surname> <given-names>VSW</given-names></string-name>, <string-name><surname>Vlachogiannis</surname> <given-names>G</given-names></string-name>, <string-name><surname>Valeri</surname> <given-names>N</given-names></string-name>, <string-name><surname>Mainolfi</surname> <given-names>N</given-names></string-name>, <string-name><surname>Suri</surname> <given-names>V</given-names></string-name>, <string-name><surname>Friedman</surname> <given-names>A</given-names></string-name>, <string-name><surname>Manfredi</surname> <given-names>M</given-names></string-name>, <string-name><surname>Blyth</surname> <given-names>K</given-names></string-name>, <string-name><surname>Sansom</surname> <given-names>OJ</given-names></string-name>, <string-name><surname>Vousden</surname> <given-names>KH</given-names></string-name></person-group>. <year>2021</year>. <article-title>Serine synthesis pathway inhibition cooperates with dietary serine and glycine limitation for cancer therapy</article-title>. <source>Nat Commun</source> <volume>12</volume>:<fpage>366</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41467-020-20223-y</pub-id></mixed-citation></ref>
<ref id="c62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tamura</surname> <given-names>R</given-names></string-name>, <string-name><surname>Miyoshi</surname> <given-names>H</given-names></string-name>, <string-name><surname>Sampetrean</surname> <given-names>O</given-names></string-name>, <string-name><surname>Shinozaki</surname> <given-names>M</given-names></string-name>, <string-name><surname>Morimoto</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Iwasawa</surname> <given-names>C</given-names></string-name>, <string-name><surname>Fukaya</surname> <given-names>R</given-names></string-name>, <string-name><surname>Mine</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Masuda</surname> <given-names>H</given-names></string-name>, <string-name><surname>Maruyama</surname> <given-names>T</given-names></string-name>, <string-name><surname>Narita</surname> <given-names>M</given-names></string-name>, <string-name><surname>Saya</surname> <given-names>H</given-names></string-name>, <string-name><surname>Yoshida</surname> <given-names>K</given-names></string-name>, <string-name><surname>Okano</surname> <given-names>H</given-names></string-name>, <string-name><surname>Toda</surname> <given-names>M.</given-names></string-name></person-group> <year>2019</year>. <article-title>Visualization of spatiotemporal dynamics of human glioma stem cell invasion</article-title>. <source>Mol Brain</source> <volume>12</volume>:<fpage>45</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13041-019-0462-3</pub-id></mixed-citation></ref>
<ref id="c63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tang</surname> <given-names>X</given-names></string-name>, <string-name><surname>Zuo</surname> <given-names>C</given-names></string-name>, <string-name><surname>Fang</surname> <given-names>P</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>G</given-names></string-name>, <string-name><surname>Qiu</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Tang</surname> <given-names>R.</given-names></string-name></person-group> <year>2021</year>. <article-title>Targeting Glioblastoma Stem Cells: A Review on Biomarkers, Signal Pathways and Targeted Therapy</article-title>. <source>Front Oncol</source> <volume>11</volume>:<fpage>701291</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fonc.2021.701291</pub-id></mixed-citation></ref>
<ref id="c64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tomita</surname> <given-names>A</given-names></string-name>, <string-name><surname>Mori</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hiwatari</surname> <given-names>K</given-names></string-name>, <string-name><surname>Yamaguchi</surname> <given-names>E</given-names></string-name>, <string-name><surname>Itoi</surname> <given-names>T</given-names></string-name>, <string-name><surname>Sunamura</surname> <given-names>M</given-names></string-name>, <string-name><surname>Soga</surname> <given-names>T</given-names></string-name>, <string-name><surname>Tomita</surname> <given-names>M</given-names></string-name>, <string-name><surname>Sugimoto</surname> <given-names>M.</given-names></string-name></person-group> <year>2018</year>. <article-title>Effect of storage conditions on salivary polyamines quantified via liquid chromatography-mass spectrometry</article-title>. <source>Sci Rep</source> <volume>8</volume>:<fpage>12075</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-018-30482-x</pub-id></mixed-citation></ref>
<ref id="c65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Williams</surname> <given-names>RE</given-names></string-name>, <string-name><surname>Lock</surname> <given-names>EA</given-names></string-name></person-group>. <year>2004</year>. <article-title>d-Serine-induced nephrotoxicity: possible interaction with tyrosine metabolism</article-title>. <source>Toxicology</source> <volume>201</volume>:<fpage>231</fpage>–<lpage>238</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tox.2004.05.001</pub-id></mixed-citation></ref>
<ref id="c66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wiriyasermkul</surname> <given-names>P</given-names></string-name>, <string-name><surname>Nagamori</surname> <given-names>S</given-names></string-name>, <string-name><surname>Tominaga</surname> <given-names>H</given-names></string-name>, <string-name><surname>Oriuchi</surname> <given-names>N</given-names></string-name>, <string-name><surname>Kaira</surname> <given-names>K</given-names></string-name>, <string-name><surname>Nakao</surname> <given-names>H</given-names></string-name>, <string-name><surname>Kitashoji</surname> <given-names>T</given-names></string-name>, <string-name><surname>Ohgaki</surname> <given-names>R</given-names></string-name>, <string-name><surname>Tanaka</surname> <given-names>H</given-names></string-name>, <string-name><surname>Endou</surname> <given-names>H</given-names></string-name>, <string-name><surname>Endo</surname> <given-names>K</given-names></string-name>, <string-name><surname>Sakurai</surname> <given-names>H</given-names></string-name>, <string-name><surname>Kanai</surname> <given-names>Y.</given-names></string-name></person-group> <year>2012</year>. <article-title>Transport of 3-Fluoro-l-α-Methyl-Tyrosine by Tumor-Upregulated L-Type Amino Acid Transporter 1: A Cause of the Tumor Uptake in PET</article-title>. <source>J Nucl Med</source> <volume>53</volume>:<fpage>1253</fpage>–<lpage>1261</lpage>. doi:<pub-id pub-id-type="doi">10.2967/jnumed.112.103069</pub-id></mixed-citation></ref>
<ref id="c67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wolosker</surname> <given-names>H.</given-names></string-name></person-group> <year>2011</year>. <article-title>Serine racemase and the serine shuttle between neurons and astrocytes</article-title>. <source>Biochimica Et Biophysica Acta Bba - Proteins Proteom</source> <volume>1814</volume>:<fpage>1558</fpage>–<lpage>1566</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbapap.2011.01.001</pub-id></mixed-citation></ref>
<ref id="c68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wolosker</surname> <given-names>H</given-names></string-name>, <string-name><surname>Balu</surname> <given-names>DT</given-names></string-name></person-group>. <year>2020</year>. <article-title>d-Serine as the gatekeeper of NMDA receptor activity: implications for the pharmacologic management of anxiety disorders</article-title>. <source>Transl Psychiatry</source> <volume>10</volume>:<fpage>184</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41398-020-00870-x</pub-id></mixed-citation></ref>
<ref id="c69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname> <given-names>JH</given-names></string-name>, <string-name><surname>Wada</surname> <given-names>A</given-names></string-name>, <string-name><surname>Yoshida</surname> <given-names>K</given-names></string-name>, <string-name><surname>Miyoshi</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Sayano</surname> <given-names>T</given-names></string-name>, <string-name><surname>Esaki</surname> <given-names>K</given-names></string-name>, <string-name><surname>Kinoshita</surname> <given-names>MO</given-names></string-name>, <string-name><surname>Tomonaga</surname> <given-names>S</given-names></string-name>, <string-name><surname>Azuma</surname> <given-names>N</given-names></string-name>, <string-name><surname>Watanabe</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hamase</surname> <given-names>K</given-names></string-name>, <string-name><surname>Zaitsu</surname> <given-names>K</given-names></string-name>, <string-name><surname>Machida</surname> <given-names>T</given-names></string-name>, <string-name><surname>Messing</surname> <given-names>A</given-names></string-name>, <string-name><surname>Itohara</surname> <given-names>S</given-names></string-name>, <string-name><surname>Hirabayashi</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Furuya</surname> <given-names>S.</given-names></string-name></person-group> <year>2010</year>. <article-title>Brain-specific Phgdh Deletion Reveals a Pivotal Role for l-Serine Biosynthesis in Controlling the Level of d-Serine, an N-methyl-d-aspartate Receptor Co-agonist, in Adult Brain*</article-title>. <source>J Biol Chem</source> <volume>285</volume>:<fpage>41380</fpage>–<lpage>41390</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.m110.187443</pub-id></mixed-citation></ref>
<ref id="c70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yoshida</surname> <given-names>K</given-names></string-name>, <string-name><surname>Furuya</surname> <given-names>S</given-names></string-name>, <string-name><surname>Osuka</surname> <given-names>S</given-names></string-name>, <string-name><surname>Mitoma</surname> <given-names>J</given-names></string-name>, <string-name><surname>Shinoda</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Watanabe</surname> <given-names>M</given-names></string-name>, <string-name><surname>Azuma</surname> <given-names>N</given-names></string-name>, <string-name><surname>Tanaka</surname> <given-names>H</given-names></string-name>, <string-name><surname>Hashikawa</surname> <given-names>T</given-names></string-name>, <string-name><surname>Itohara</surname> <given-names>S</given-names></string-name>, <string-name><surname>Hirabayashi</surname> <given-names>Y.</given-names></string-name></person-group> <year>2004</year>. <article-title>Targeted Disruption of the Mouse 3-Phosphoglycerate Dehydrogenase Gene Causes Severe Neurodevelopmental Defects and Results in Embryonic Lethality*</article-title>. <source>J Biol Chem</source> <volume>279</volume>:<fpage>3573</fpage>–<lpage>3577</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.c300507200</pub-id></mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.108562.1.sa3</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Parker</surname>
<given-names>Benjamin L</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>The University of Melbourne</institution>
</institution-wrap>
<city>Melbourne</city>
<country>Australia</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Incomplete</kwd>
<kwd>Solid</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Valuable</kwd>
</kwd-group>
</front-stub>
<body>
<p>This work presents <bold>valuable</bold> new data on the role of D-Serine and how it competes with its stereoisomer L-Serine to influence metabolism. The work presents a variety of <bold>solid</bold> experimental data combined with simulated results to investigate the mechanisms focused on one-carbon metabolism, which is relevant for several research fields. However, some claims are only partially supported by data, and critical areas comparing L- vs D-Serine and further mechanistic studies are <bold>incomplete</bold>. Furthermore, while the work has potential for various fields, the work has only been studied in a limited cell type and context.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.108562.1.sa2</article-id>
<title-group>
<article-title>Reviewer #1 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>The authors demonstrate the stereoselective role of D-serine in 1C metabolism, showing that D-serine competes with L-serine and inhibits mitochondrial L-serine transport. They observe expression of 1C metabolites in their metabolomics approach in primary cortical neurons treated with L-serine, D-serine, and a mixture of both. Their conclusions are based on the reduction in levels of glycine, polyamines, and their intermediates and formate. Single-cell RNA sequencing of N2a cells showed that cells treated with D-serine enhanced expression of genes associated with mitochondrial functions, such as respiratory chain complex assembly, and mitochondrial functions, with downregulation of genes related to amino acid transport, cellular growth, and neuron projection extension. Their work demonstrates that D-serine inhibits tumor cell proliferation and induces apoptosis in neural progenitor cells, highlighting the importance of D-serine in neurodevelopment.</p>
<p>Strengths:</p>
<p>D-amino acids are a marvel of nature. It is fascinating that nature decided to make two versions of the same molecule, in this case, an amino acid. While the L-stereoisomer plays well-known roles in biology, the D-stereoisomer seems to function in obscurity. Research into these novel signaling molecules is gathering momentum, with newer stereoisomers being discovered. D-serine has been the most well-studied among the different stereoisomers, and we still continue to learn about this novel neurotransmitter. The roles of these molecules in the context of metabolism is not well studied. The authors aim to elucidate the metabolic role of D-serine in the context of neuronal maturation with implications for 1C metabolism and in cell proliferation. The metabolic role of these molecules is just beginning to be uncovered, especially in the context of mammalian biology. This is the strength of the manuscript. The authors have done important work in prior publications elucidating the role of D-amino acids. The advancement of the field of D-amino acids in mammalian biology is significant, as not much is known. The presentation of RNA seq data is a valuable resource to the community, however, with caveats as mentioned below.</p>
<p>Weaknesses:</p>
<p>The following are some of the issues that come out in a critical reading of the manuscript. Addressing these would only strengthen and clarify the work.</p>
<p>(1) Kinetic assessment of D-serine versus L-serine: While the authors mention that D-serine is not a good substrate for SHMT2 compared to L-serine, the kinetic data are presented for only D-serine. In a substrate comparison with an enzyme, data must be presented for L-serine as well to make the conclusion about substrate specificity and affinity. Since the authors talk about one versus another substrate, there needs to be a kinetic comparison of both with Km (affinity). (Ref Figure 2 panel).</p>
<p>(2) Molecular Dynamics simulations, while a good first step in modeling interactions at the active site, rely on force fields. These force fields are approximations and do not represent all interactions occurring in the natural world. Setting up the initial conditions in the simulations can impact the final results in non-equilibrium scenarios. The basic question here is this: Is the simulated trajectory long enough so that the system reaches thermodynamic equilibrium and the measured properties converge? Prior studies have shown mixed results with the conclusion that properties of biological systems tend to converge in multi-second trajectories (not nanosecond scales as reported by the authors) and transition rates to low probability conformations require more time. (Ref Figure 2C).</p>
<p>(3) The authors use N2a cell line to demonstrate D-serine burden on primary cortical neurons. N2a is an immortalized cell line, and its properties are very different from primary neurons. The authors need to mention a rationale for the use of an immortalized cell line versus primary neurons. The transcriptomic profile of an immortalized cell line is different compared to a primary cell. Hence, the response to D-serine may vary between the two different cell types.</p>
<p>(4) In Figure 4D, the authors mention that D-serine activates the cleavage of caspase 3. Figure 4D shows only cleaved caspase 3 as a single band. They need to show the full blot that contains the cleaved fragments along with the major caspase 3 band.</p>
<p>(5) In Figure panel 4, the authors use neural progenitor cells (NPCs). They need to demonstrate that the population they are working with is NPCs and not primary neurons. There must be a figure panel staining for NPC markers like SOX2 and PAX6. Also, Figure S5 needs to be properly labeled. It is confusing from the legend what panels B-E refer to? Also, scale bars are not indicated.</p>
<p>(6) In Supplementary Figure panel 7F, the authors mention phosphatidyl L-serine and phosphatidyl D-serine. A chromatogram of the two species would clarify their presence as they used 2D-HPLC. On an MS platform, these 2 species are not distinguishable. Including a chromatogram of the 2 species would be helpful to the readers.</p>
<p>(7) The authors mention about enantiomeric shift of serine metabolism during neural development, which appears to be a discussion of prior published data from Hubbard et al, 2013, Burk et al, 2020, and Bella et a,l 2021 in Supplementary Figure panels 8 A-E. This should not be presented as a figure panel, as it gives the false impression that the authors have performed the experiment, which is clearly not the case. However, its discussion can well serve as part of the manuscript in the discussion section.</p>
<p>(8) The entire presentation of the section on enantiomeric shift of serine metabolism during neural development (lines 274-312) is a discussion and should be part of the discussion section and not in the results section. This is misleading.</p>
<p>(9) The discussion section is not well written. There is no mention of recent work related to D-serine that has a direct bearing on its metabolic properties. In the discussion section, paragraph 1, the authors mention that their work demonstrates the selective synthesis of D-serine in mature neurons as opposed to neural progenitor cells. This concept has been referred to in prior publications:</p>
<p>(a) Spatiotemporal relationships among D-serine, serine racemase, and D-amino acid oxidase during mouse postnatal development. PMID:14531937.</p>
<p>(b) D-cysteine is an endogenous regulator of neural progenitor cell dynamics in the mammalian brain. PMID:34556581.</p>
<p>(10) In the abstract, in lines 101 and 102, the authors mention &quot;how D-serine contributes to cellular metabolism beyond neurotransmission remains largely unknown&quot;. In 2023, a paper in Stem Cell Reports by Roychaudhuri et al (PMID:37352848) showed that D and L-serine availability impacts lipid metabolism in the subventricular zone in mice, affecting proliferative properties of stem-cell derived neurons using a comprehensive lipidomics approach. There is no mention of this work even in the discussion section, as it bears directly on L and D-serine availability in neurons, which the authors are investigating. In the discussion section in lines 410-411, the authors mention the role of D-serine in neurogenesis, but surprisingly don't refer to the above reference. The role of D-serine in neurogenesis has been demonstrated in the Sultan et al (lines 855-857) and Roychaudhuri et al references.</p>
<p>(11) Both D-serine and the structurally similar stereoisomer D-cysteine (sulfur versus oxygen atom) have a bearing on 1C metabolism and the folate cycle. With reference to the folate cycle, Roychaudhuri et al in 2024 (PMID:39368613) have shown in rescue experiments in mice that supplementing a higher methionine diet provides folate cycle precursors to rescue the high insulin phenotype in SR-deficient mice. Since 1C metabolism is being discussed in this manuscript, the authors seem to overlook prior work in the field and not include it in their discussion, even when it is the same enzyme (SR) that synthesizes both serine and cysteine. Since the field of D-amino acid research is in its infancy, the authors must make it a point to include prior work related to D-serine at least, and not claim that it is not known. The known D-stereoisomers are not many, hence any progress in the area must include at least a discussion of the other structurally related stereoisomers.</p>
<p>(12) Racemases (serine and aspartate) in general are promiscuous enzymes and known to synthesize other stereoisomers in addition to D-serine, D-cysteine, and D-aspartate. A few controls, like D-aspartate, D-cysteine, or even D-alanine must be included in their study to demonstrate the specific actions of D-serine, especially in the N2a cell treatment experiments. Cysteine and Serine are almost identical in structure (sulfur versus oxygen atom), and both are synthesized by serine racemase (published). Cysteine has also been very recently shown to inhibit tumor growth and neural progenitor cell proliferation. (PMIDs: 40797101 and 34556581). How the authors' work relates to the existing findings must be discussed, and this would put things in perspective for the reader.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.108562.1.sa1</article-id>
<title-group>
<article-title>Reviewer #2 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>This study by Suzuki et al. reports an interesting stereo-selective role of D-serine in regulating one-carbon metabolism during neurodevelopment to adapt the functional transition, probably through the competition with mitochondrial transport of L-serine. The authors provide a multi-layered set of evidence, including metabolomics, enzyme assays, mitochondrial transport competition, and functional assays in immature/neural progenitor cells, to build up a conceptual integration of D-serine as both a neurotransmitter and a metabolic regulator in the central neural system, which raises a broad potential interest to the neuroscience and metabolism communities.</p>
<p>Strengths:</p>
<p>This work provides a conceptual advance that D-serine not only serves as a traditional neurotransmitter in the central neural system but also critically contributes to metabolic regulation of neural cells. The authors performed solid metabolomic assays to validate the suppressive effect of D-serine on the one-carbon metabolic pathway, providing some evidence that D-serine competitively inhibits mitochondrial serine transport, but not directly impairs SHMT2 enzymatic activity. All these data indicate a critical role of D-serine synthesis during neural maturation and suggest a potential translational strategy for targeting serine metabolism in neural tumors.</p>
<p>Weaknesses:</p>
<p>(1) The detailed mechanism by which D-serine competes with L-serine for its mitochondrial transport is not investigated. For example, although the authors made some discussion, they did not provide direct genetic or biochemical evidence linking these effects to the specific transporters, such as SFXN1.</p>
<p>(2) Unlike tumor cells, where SHMT2 usually plays a predominant role in catalyzing serine/THF-derived one-carbon metabolism, normal cells may employ both SHMT1 and SHMT2 to do the work. Even under certain conditions that SHMT2-mediated one-carbon metabolism is suppressed, the activity of SHMT1 could be elevated for compensation. Thus, it is important to investigate whether D-serine affects SHMT1 activity or changes the balance between SHMT1- and SHMT2-mediated one-carbon metabolism. To this aim, the authors are strongly encouraged to perform a metabolic flux assay (MFA) by using 13C-labeled L-serine in the model cells in the presence and absence of D-serine.</p>
<p>(3) A defect in serine-derived one-carbon metabolism may cause multiple cellular stress responses. It is valuable to detect whether cellular NADPH/NADH, GSH, or ROS is altered before and after D-serine treatment.</p>
<p>(4) The physiological relevance between D-serine and neural cell maturation/death should be further tested and discussed, since the dosage of D-serine used in the in vitro assay is much higher than that in physiological conditions.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.108562.1.sa0</article-id>
<title-group>
<article-title>Reviewer #3 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>This manuscript presents a comprehensive and well-executed investigation into the metabolic role of D-serine in the central nervous system. The authors provide solid evidence that D-serine competitively inhibits mitochondrial L-serine transport, thereby impairing one-carbon metabolism. This stereoselective mechanism reduces glycine and formate production, suppresses cellular proliferation, and induces apoptosis in immature neural cells and glioblastoma stem cells. Developmental analyses further reveal a physiological enantiomeric shift in serine metabolism during neurogenesis, aligning with the transition from proliferation to maturation. Overall, the study bridges developmental neurobiology, cancer metabolism, and amino acid transport, uncovering a previously unrecognized metabolic function of D-serine beyond its role in neurotransmission.</p>
<p>Strengths:</p>
<p>(1) The discovery that D-serine inhibits one-carbon metabolism by competing for mitochondrial L-serine transport-rather than through enzymatic inhibition or receptor-mediated signaling-represents a significant and previously underappreciated mechanism. This finding has broad implications for understanding metabolic regulation during neurodevelopment and offers potential relevance for targeting metabolic vulnerabilities in cancer.</p>
<p>(2) The authors integrate metabolomics, mitochondrial transport assays, molecular dynamics simulations, genetic and pharmacologic perturbations, transcriptomics, and both in vitro and ex vivo models. The breadth of experimental approaches, combined with the coherence of the findings across systems, provides strong support for the central conclusions and enhances the overall impact of the study.</p>
<p>(3) The temporal shift in D-/L-serine levels during neurodevelopment is elegantly linked to the transition from proliferative to mature neuronal states. The selective vulnerability of neural progenitors and tumor cells-contrasted with the resistance of mature neurons-highlights a biologically meaningful and potentially targetable metabolic distinction.</p>
<p>Weaknesses:</p>
<p>(1) While the authors attribute D-serine's metabolic effects to competition with mitochondrial L-serine transport, the specific identity of the transporter(s) mediating this process remains undefined. This represents a meaningful mechanistic gap, as the central conclusion depends on D-serine limiting mitochondrial L-serine availability to inhibit one-carbon metabolism.</p>
<p>(2) The effective concentrations of D-serine used in vitro (IC₅₀ ≈ 1-2 mM) exceed typical brain levels (~0.3 mM). While the authors acknowledge this, a more focused discussion on whether higher local D-serine concentrations could arise in specific microenvironments - such as synaptic compartments, tumor niches, or pathological states-would help contextualize the in vitro findings and strengthen their physiological relevance. For example, disruptions in D-serine clearance or altered expression of serine racemase and transporters in disease contexts could lead to localized accumulation. Moreover, differences between extracellular and intracellular D-serine pools - and the mechanisms governing their regulation - may further influence its metabolic impact in vivo.</p>
<p>(3) While the manuscript focuses on neural stem/progenitor cells and neural tumors, it remains unclear whether the anti-proliferative effects of D-serine are specific to neural lineages or extend to other highly proliferative non-neural cell types. A brief discussion addressing this point would help clarify the scope of D-serine's metabolic impact and whether its mechanism of action reflects a unique vulnerability in neural cells or a more general feature of proliferative metabolism. This distinction is particularly relevant for assessing the broader therapeutic potential of targeting mitochondrial L-serine transport.</p>
</body>
</sub-article>
</article>